00000000|MMI|125.22|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-62-"DISCHARGE"-noun-0,"Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharge"-tx-12-"DISCHARGE"-noun-0,"Discharge"-tx-4-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|5787/9;5588/9;1863/9;477/9;177/9;257/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|91.02|Portugal|C0032729|[geoa]|["PO"-tx-52-"po"-noun-0,"PO"-tx-26-"PO"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|5229/2;3459/2;[1181/2],[1245/2],[1556/2];709/2;[512/2],[562/2]|Z01.542.727
00000000|MMI|87.56|Obesity|C0028754|[dsyn]|["OBESITY"-tx-58-"obesity"-noun-0,"OBESE"-tx-33-"obese"-adj-0,"OBESITY"-tx-23-"OBESITY"-noun-0]|TX|5501/7;3818/5;3170/7|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|85.21|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-53-"lisinopril"-noun-0,"Lysinopril"-tx-52-"lisinopril"-noun-0,"Lysinopril"-tx-19-"lisinopril"-noun-0,"Lysinopril"-tx-8-"LISINOPRIL"-noun-0,"Lysinopril"-tx-7-"LISINOPRIL"-noun-0]|TX|5269/10;5201/10;2781/10;1000/10;765/10|D12.644.456.345.600
00000000|MMI|83.96|Rabbi|C0684010|[prog]|["R."-tx-55-"r"-noun-0,"R."-tx-45-"R"-noun-0,"R."-tx-38-"R"-noun-0,"R."-tx-37-"R"-noun-0,"R."-tx-14-"R"-noun-0,"R."-tx-12-"R"-noun-0]|TX|5335/1;4843/1;4392/1;4304/1;2175/1;2067/1|M01.526.799.500
00000000|MMI|83.65|Mongolia|C0026410|[geoa]|["MG"-tx-52-"mg"-noun-0,"MG"-tx-26-"MG"-noun-0,"MG"-tx-8-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0]|TX|5226/2;3456/2;[1089/2],[1178/2],[1242/2];509/2|Z01.252.474.651
00000000|MMI|68.60|Coding|C0009219|[ocac]|["code"-tx-59-"Code"-noun-0,"code"-tx-4-"CODE"-noun-0,"code"-tx-4-"code"-noun-0]|TX|5556/4;424/4;442/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|66.29|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-8-"POTASSIUM CHLORIDE"-noun-0,"POTASSIUM CHLORIDE"-tx-7-"POTASSIUM CHLORIDE"-noun-0,"POTASSIUM CHLORIDE"-tx-5-"POTASSIUM CHLORIDE"-noun-0]|TX|[925/18],[1017/18];782/18;678/18|D01.210.450.150.750;D01.745.625
00000000|MMI|57.90|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-51-"ASA"-noun-0,"ASA"-tx-26-"Asa"-noun-0]|TX|5109/3;3449/3|D02.455.426.559.389.657.410.595.176
00000000|MMI|49.24|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-26-"Lipitor"-noun-0,"Lipitor"-tx-19-"lipitor"-noun-0,"Lipitor"-tx-8-"LIPITOR"-noun-0]|TX|3377/7;2795/7;1150/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|48.98|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-26-"SC"-noun-0,"SC"-tx-8-"SC"-noun-0]|TX|3370/2;[1380/2],[1496/2]|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-12-"DIAGNOSIS"-noun-0,"diagnosis"-tx-11-"DIAGNOSIS"-noun-0]|TX|1959/9;1821/9|x.x.x.x.x.x.x
00000000|MMI|47.09|Lesion|C0221198|[fndg]|["Lesion"-tx-48-"lesion"-noun-1,"lesions"-tx-48-"lesions"-noun-1,"Lesion"-tx-47-"lesion"-noun-0,"lesions"-tx-46-"lesions"-noun-1,"Lesion"-tx-41-"lesion"-noun-1,"lesions"-tx-41-"lesions"-noun-1,"Lesion"-tx-40-"lesion"-noun-0,"lesions"-tx-39-"lesions"-noun-1]|TX|[4996/6],[5034/6];4974/7;4914/6;4880/7;[4545/6],[4583/6];4523/7;4463/6;4429/7|
00000000|MMI|45.92|Adrenergic beta-Antagonists|C0001645|[phsu]|["Beta Blocker"-tx-55-"beta blocker"-noun-0,"Beta Blocker"-tx-53-"betablocker"-noun-0]|TX|5352/12;5282/11|D27.505.519.625.050.200.200;D27.505.696.577.050.200.200
00000000|MMI|45.33|Lantus|C0876064|[aapp,phsu]|["Lantus"-tx-26-"Lantus"-noun-0,"Lantus"-tx-8-"LANTUS"-noun-0]|TX|3354/6;1343/6|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|45.20|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-51-"ASA"-noun-0,"ASA"-tx-26-"Asa"-noun-0]|TX|5109/3;3449/3|D08.811.277.352.827.070.250
00000000|MMI|45.03|Humalog|C0528249|[aapp,phsu]|["Humalog"-tx-26-"Humalog"-noun-0,"Humalog"-tx-8-"HUMALOG"-noun-0]|TX|3419/7;1452/7|D06.472.699.587.200.400.500;D12.644.548.586.200.400.500
00000000|MMI|40.50|Dyspnea|C0013404|[sosy]|["SOB"-tx-43-"SOB"-noun-0,"SOB"-tx-17-"SOB"-noun-0,"SOB"-tx-14-"SOB"-noun-0]|TX|4687/3;2656/3;2237/3|C08.618.326;C23.888.852.371
00000000|MMI|35.81|Togo|C0040363|[geoa]|["TO"-tx-10-"to"-adv-0,"TO"-tx-8-"to"-adv-0]|TX|1769/2;1325/2|Z01.058.290.190.800
00000000|MMI|35.81|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-10-"to"-adv-0,"TO"-tx-8-"to"-adv-0]|TX|1769/2;1325/2|D08.811.520.224.800
00000000|MMI|33.49|Override|C1547671|[acty]|["Override"-tx-8-"override"-verb-0,"Override"-tx-7-"Override"-verb-0,"Override"-tx-7-"override"-verb-0,"Override"-tx-4-"Override"-verb-0]|TX|1047/8;859/8;[812/8],[837/8];[595/8],[612/8]|
00000000|MMI|33.21|+2|C0740116|[qnco]|["+2"-tx-33-"2"-integer-0,"+2"-tx-18-"2"-integer-0,"+2"-tx-11-"2"-integer-0,"+2"-tx-8-"2"-fraction-0,"+2"-tx-4-"2"-fraction-0]|TX|3930/1;2734/1;1793/1;[1209/1],[1274/1],[1408/1];[538/1],[588/1]|
00000000|MMI|33.21|2+|C3833492|[fndg]|["2+"-tx-33-"2"-integer-1,"2+"-tx-18-"2"-integer-0,"2+"-tx-11-"2"-integer-0,"2+"-tx-8-"2"-fraction-0,"2+"-tx-4-"2"-fraction-0]|TX|3930/1;2734/1;1793/1;[1209/1],[1274/1],[1408/1];[538/1],[588/1]|
00000000|MMI|33.21|2+ Score|C2827735|[qnco]|["2+"-tx-33-"2"-integer-0,"2+"-tx-18-"2"-integer-0,"2+"-tx-11-"2"-integer-0,"2+"-tx-8-"2"-fraction-0,"2+"-tx-4-"2"-fraction-0]|TX|3930/1;2734/1;1793/1;[1209/1],[1274/1],[1408/1];[538/1],[588/1]|
00000000|MMI|33.21|2+ Score, WHO|C2981700|[clas]|["2+"-tx-33-"2"-integer-0,"2+"-tx-18-"2"-integer-0,"2+"-tx-11-"2"-integer-0,"2+"-tx-8-"2"-fraction-0,"2+"-tx-4-"2"-fraction-0]|TX|3930/1;2734/1;1793/1;[1209/1],[1274/1],[1408/1];[538/1],[588/1]|
00000000|MMI|32.94|Chest Pain|C0008031|[sosy]|["CHEST PAIN"-tx-14-"chest pain"-noun-0,"CHEST PAIN"-tx-8-"chest pain"-noun-0]|TX|2222/10;1117/10|C10.597.617.192;C23.888.592.612.233
00000000|MMI|32.66|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-59-"regimen"-noun-0,"Regimen"-tx-57-"regimen"-noun-0]|TX|5640/7;5412/7|E02.183;N05.715.360.775.225
00000000|MMI|32.58|Oral|C0442027|[spco]|["PO"-tx-52-"po"-noun-0,"PO"-tx-26-"PO"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|5229/2;3459/2;[1181/2],[1245/2],[1556/2];709/2;[512/2],[562/2]|
00000000|MMI|32.47|Left Ventricular Hypertrophy|C0149721|[dsyn]|["LVH"-tx-54-"LVH"-noun-0,"LVH"-tx-24-"LVH"-noun-0]|TX|5321/3;3235/3|C14.280.195.400;C23.300.775.250.400
00000000|MMI|32.31|Ivory Coast|C0022326|[geoa]|["IV"-tx-22-"IV"-noun-0,"IV"-tx-8-"IV"-noun-0]|TX|3019/2;944/2|Z01.058.290.190.272
00000000|MMI|32.26|Hyperlipidemia|C0020473|[dsyn]|["Hyperlipidaemia, NOS"-tx-23-"HYPERLIPIDEMIA"-noun-0,"Hyperlipidaemia, NOS"-tx-14-"hyperlipidemia"-noun-0]|TX|3178/14;2292/14|C18.452.584.500.500
00000000|MMI|27.11|Daily|C0332173|[tmco]|["QD"-tx-52-"qd"-noun-0,"QD"-tx-26-"QD"-adv-0,"QD"-tx-26-"QD"-noun-0,"Daily"-tx-8-"DAILY"-adj-0,"Daily"-tx-8-"DAILY"-adv-0,"Daily"-tx-4-"DAILY"-adv-0]|TX|5232/2;[3393/2],[3462/2];[3393/2],[3462/2];[1248/5],[1559/5];[1248/5],[1559/5];[515/5],[565/5]|
00000000|MMI|26.52|ECHO protocol|C0058928|[topp]|["ECHO"-tx-54-"Echo"-noun-0,"ECHO"-tx-23-"echo"-verb-0]|TX|5295/4;3198/4|x.x.x.x
00000000|MMI|26.40|phosphoethanolamine|C0070939|[bacs,orch]|["PE"-tx-34-"PE"-noun-0]|TX|[4053/2],[4062/2]|x.x.x.x
00000000|MMI|26.37|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-59-"PLAN"-noun-0,"PLAN"-tx-42-"PLAN"-noun-0]|TX|5622/4;4647/4|C10.228.140.744
00000000|MMI|26.18|Awareness|C0004448|[menp]|["Aware"-tx-8-"aware"-adj-0,"Aware"-tx-7-"aware"-adj-0]|TX|1057/5;822/5|F02.463.188.150
00000000|MMI|25.94|Mental Depression|C0011570|[mobd]|["DEPRESSION"-tx-28-"depression"-noun-0,"DEPRESSION"-tx-23-"DEPRESSION"-noun-0]|TX|3649/10;3159/10|F01.145.126.350
00000000|MMI|24.11|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|[orch,phsu]|["Statin"-tx-51-"statin"-noun-0]|TX|5124/6|D27.505.519.186.071.202.370;D27.505.519.389.370;D27.505.954.557.500.202.370
00000000|MMI|24.11|Insulin Glargine|C0907402|[aapp,horm,phsu]|["INSULIN GLARGINE"-tx-8-"INSULIN GLARGINE"-noun-0]|TX|1352/16|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|24.11|Insulin Lispro|C0293359|[aapp,horm,phsu]|["INSULIN LISPRO"-tx-8-"INSULIN LISPRO"-noun-0]|TX|1470/14|D06.472.699.587.200.400.500;D12.644.548.586.200.400.500
00000000|MMI|23.18|Specimen Source Codes - Lesion|C1546698|[inpr]|["Lesion"-tx-48-"lesion"-noun-0,"Lesion"-tx-47-"lesion"-noun-0,"Lesion"-tx-41-"lesion"-noun-0,"Lesion"-tx-40-"lesion"-noun-0]|TX|[4996/6],[5034/6];4914/6;[4545/6],[4583/6];4463/6|
00000000|MMI|22.80|R prime|C2603358|[clna]|["R'"-tx-55-"r"-noun-0,"R'"-tx-45-"R"-noun-0,"R'"-tx-38-"R"-noun-0,"R'"-tx-37-"R"-noun-0,"R'"-tx-14-"R"-noun-0,"R'"-tx-12-"R"-noun-0]|TX|5335/1;4843/1;4392/1;4304/1;2175/1;2067/1|
00000000|MMI|22.80|Right|C0205090|[spco]|["R-"-tx-55-"r"-noun-0,"R-"-tx-45-"R"-noun-0,"R-"-tx-38-"R"-noun-0,"R-"-tx-37-"R"-noun-0,"R-"-tx-14-"R"-noun-0,"R-"-tx-12-"R"-noun-0]|TX|5335/1;4843/1;4392/1;4304/1;2175/1;2067/1|
00000000|MMI|22.56|Insulin|C0021641|[aapp,horm,phsu]|["INSULIN"-tx-8-"INSULIN"-noun-0]|TX|1460/7|D06.472.699.587.200.500.625;D12.644.548.586.200.500.625
00000000|MMI|22.54|Surgical aspects|C0038895|[ftcn]|["operations"-tx-12-"OPERATIONS"-noun-0]|TX|2040/10|x.x.x.x.x.x.x
00000000|MMI|22.49|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-52-"mg"-noun-0,"Mg++"-tx-26-"MG"-noun-0,"Mg++"-tx-8-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0]|TX|5226/2;3456/2;[1089/2],[1178/2],[1242/2];509/2|
00000000|MMI|22.49|Milligram percent|C1960952|[qnco]|["mg %"-tx-52-"mg"-noun-0,"mg %"-tx-26-"MG"-noun-0,"mg %"-tx-8-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0]|TX|5226/2;3456/2;[1089/2],[1178/2],[1242/2];509/2|
00000000|MMI|22.49|mg/dL|C0439269|[qnco]|["mg%"-tx-52-"mg"-noun-0,"mg%"-tx-26-"MG"-noun-0,"mg%"-tx-8-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0]|TX|5226/2;3456/2;[1089/2],[1178/2],[1242/2];509/2|
00000000|MMI|22.40|Walking (activity)|C0080331|[dora]|["Walking"-tx-14-"walking"-adj-0]|TX|2475/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|22.39|Burkitt Lymphoma|C0006413|[neop]|["BL"-tx-33-"BL"-noun-0]|TX|3861/2|C02.256.466.313.165;C02.928.313.165;C04.557.386.480.150.165;C15.604.515.569.480.150.165;C20.683.515.761.480.150.165
00000000|MMI|22.39|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-12-"Treatment"-noun-0]|TX|2021/9|x.x.x.x.x.x.x
00000000|MMI|21.36|Diffuse|C0205219|[qlco]|["DIFFUSE"-tx-48-"diffuse"-verb-0,"DIFFUSE"-tx-47-"DIffuse"-verb-0,"DIFFUSE"-tx-41-"diffuse"-verb-0,"DIFFUSE"-tx-40-"DIffuse"-verb-0]|TX|5022/7;4889/7;4571/7;4438/7|
00000000|MMI|21.36|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-61-"M.D"-noun-0,"M.D."-tx-8-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|5747/3;907/3;660/3;411/3|
00000000|MMI|20.95|Lovenox|C0728963|[orch,phsu]|["Lovenox"-tx-58-"lovenox"-noun-0]|TX|5529/7|D09.698.373.400.300.200
00000000|MMI|20.95|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-33-"NAD"-noun-0]|TX|3804/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|20.30|Disease|C0012634|[dsyn]|["condition"-tx-59-"CONDITION"-noun-0,"condition"-tx-12-"Conditions"-noun-0]|TX|5598/9;1969/10|C23.550.288
00000000|MMI|20.23|Appointments|C0003629|[idcn]|["Appointment"-tx-10-"appointment"-noun-0,"Appointment"-tx-8-"APPOINTMENT"-noun-0]|TX|1780/11;1645/11|N04.452.095
00000000|MMI|19.82|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-44-"ischemia"-noun-1,"Ischaemia, NOS"-tx-36-"ischemia"-noun-0]|TX|4780/8;4274/8|C23.550.513
00000000|MMI|19.82|Edema|C0013604|[fndg]|["OEDEMA"-tx-33-"edema"-noun-1,"OEDEMA"-tx-20-"edema"-noun-0]|TX|3917/5;2870/5|C23.888.277
00000000|MMI|19.60|Depressive disorder|C0011581|[mobd]|["-- Depression"-tx-28-"depression"-noun-0,"-- Depression"-tx-23-"DEPRESSION"-noun-0]|TX|3649/10;3159/10|F03.600.300
00000000|MMI|19.57|Stenosis|C1261287|[patf]|["Stenosis"-tx-47-"stenosis"-noun-0,"Stenosis"-tx-40-"stenosis"-noun-0]|TX|4936/8;4485/8|C23.300.287
00000000|MMI|19.45|Lopressor|C0700776|[orch,phsu]|["Lopressor"-tx-52-"lopressor"-noun-0]|TX|5141/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|19.38|Acid Ceramidase|C2350443|[aapp,enzy]|["AC"-tx-8-"AC"-noun-0]|TX|1499/2|D08.811.277.087.250.100
00000000|MMI|19.38|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-22-"lasix"-noun-0]|TX|3022/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|19.38|Order (action)|C1705178|[acty]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5797/6;915/5;668/5;339/5;187/6|
00000000|MMI|19.38|Order (arrangement)|C1705176|[qlco]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5797/6;915/5;668/5;339/5;187/6|
00000000|MMI|19.38|Order (document)|C1705175|[inpr]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5797/6;915/5;668/5;339/5;187/6|
00000000|MMI|19.38|Order (taxonomic)|C1705177|[clas]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5797/6;915/5;668/5;339/5;187/6|
00000000|MMI|19.38|Permutation|C1882348|[qlco]|["Order"-tx-62-"ORDERS"-verb-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5797/6;915/5;668/5;339/5;187/6|
00000000|MMI|19.38|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-62-"ORDERS"-verb-0,"ORDER"-tx-8-"order"-noun-0,"ORDER"-tx-5-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5797/6;915/5;668/5;339/5;187/6|
00000000|MMI|19.36|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-52-"atenolol"-noun-0]|TX|5176/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|19.31|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|335/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|19.25|Po 12|C1569564|[orch,phsu]|["Po 12"-tx-26-"PO 12"-noun-0]|TX|3390/2,3427/2|D02.455.849.919.530.444
00000000|MMI|19.24|Nuchal Translucency Screen|C1449832|[diap]|["NT"-tx-33-"NT"-noun-0]|TX|3899/2|E01.370.350.850.865.500;E01.370.378.630.865.500
00000000|MMI|19.23|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-26-"meals"-noun-0]|TX|3443/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|19.20|Registries|C0034975|[inpr]|["Registry"-tx-26-"registry"-noun-0]|TX|3551/8|E05.318.308.970;L01.280.950;N04.452.859.819;N05.715.360.300.715.700;N06.850.520.308.970
00000000|MMI|19.02|30%|C3842588|[fndg]|["30%"-tx-52-"30"-integer-0,"30%"-tx-8-"30"-fraction-0,"30%"-tx-4-"30"-fraction-0]|TX|5223/2;[1211/2],[1410/2];[540/2],[590/2]|
00000000|MMI|18.92|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-62-"DISCHARGE"-noun-0,"Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharge"-tx-12-"DISCHARGE"-noun-0,"Discharge"-tx-4-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5787/9;5588/9;1863/9;477/9;177/9|
00000000|MMI|18.92|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-62-"DISCHARGE"-noun-0,"Discharge"-tx-59-"DISCHARGE"-noun-0,"Discharge"-tx-12-"DISCHARGE"-noun-0,"Discharge"-tx-4-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5787/9;5588/9;1863/9;477/9;177/9|
00000000|MMI|18.04|Beginning|C0439659|[tmco]|["Start"-tx-8-"Starting"-adj-0,"Start"-tx-4-"Starting"-adj-0]|TX|[1192/8],[1254/8],[1391/8];[521/8],[571/8]|
00000000|MMI|17.80|Deep Vein Thrombosis|C0149871|[dsyn]|["DVT NOS"-tx-34-"DVT"-noun-1]|TX|4068/3|C14.907.355.830.925
00000000|MMI|17.80|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-35-"EKG"-noun-0]|TX|4175/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|17.80|Electrocardiography|C1623258|[diap]|["EKG"-tx-35-"EKG"-noun-0]|TX|4175/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|17.80|Pulse Rate|C0232117|[clna]|["PULSE"-tx-33-"pulses"-verb-0]|TX|3935/6|E01.370.600.875.500;G09.330.380.500
00000000|MMI|17.80|Pulse taking|C0034107|[hlca]|["Pulses"-tx-33-"pulses"-verb-0]|TX|3935/6|E01.370.370.380.650;E01.370.600.650;G09.330.380.750
00000000|MMI|16.30|Central African Republic|C0007673|[geoa]|["CT"-tx-34-"CT"-noun-0]|TX|4056/2|Z01.058.290.100.120
00000000|MMI|16.30|Lesotho|C0023376|[geoa]|["LT"-tx-8-"lt"-noun-0]|TX|1142/2|Z01.058.290.175.400
00000000|MMI|16.30|Thyroid Nodule|C0040137|[neop]|["Thyroid Nodules"-tx-34-"thyroid nodules"-noun-1]|TX|4083/15|C04.588.322.894.800;C04.588.443.915.800;C19.344.894.800;C19.874.788.800
00000000|MMI|16.25|Compliance behavior|C1321605|[inbe]|["COMPLIANCE"-tx-14-"compliance"-noun-0]|TX|2335/10|F01.145.488.500;N05.300.150.600.600
00000000|MMI|16.23|Antigua and Barbuda|C0003354|[geoa]|["AC"-tx-8-"AC"-noun-0]|TX|1499/2|Z01.107.084.900.050;Z01.639.880.050
00000000|MMI|16.23|Nitroglycerin|C0017887|[orch,phsu]|["nitroglycerine"-tx-8-"NITROGLYCERIN"-noun-0]|TX|1063/13|D02.033.800.421.560;D02.640.636
00000000|MMI|16.18|Cardiac Catheterization Procedures|C0018795|[hlca]|["heart Catheterisation"-tx-12-"heart catheterization"-noun-0]|TX|2073/21|E01.370.370.380.140;E02.148.442;E05.157.250
00000000|MMI|16.16|Sick Days|C0242806|[idcn]|["Illness Day"-tx-14-"worse day"-noun-0]|TX|2443/5,2452/3|N01.824.417.700.662;N04.452.677.800.662
00000000|MMI|16.12|Fat-Restricted Diet|C0242970|[topp]|["low fat"-tx-8-"Low fat"-noun-0]|TX|1579/3,1597/3|E02.642.249.260;G07.203.650.240.260
00000000|MMI|16.12|Myelofibrosis|C0026987|[neop]|["MMM"-tx-33-"MMM"-noun-0]|TX|3846/3|C15.378.190.636.765
00000000|MMI|16.09|Lebanon|C0023190|[geoa]|["LE"-tx-20-"LE"-noun-0]|TX|2867/2|Z01.252.245.500.450
00000000|MMI|16.09|Saint Lucia|C0036056|[geoa]|["ST"-tx-35-"ST"-adj-0]|TX|4204/2|Z01.107.084.900.825;Z01.639.880.825
00000000|MMI|16.05|Exercise stress test|C0015260|[diap]|["stress test"-tx-25-"stress test"-noun-0]|TX|3266/11|E01.370.370.380.250;E01.370.386.700.250;E05.333.250
00000000|MMI|16.05|Stress Test|C3494508|[diap]|["Stress Test"-tx-25-"stress test"-noun-0]|TX|3266/11|E01.370.370.380.250;E01.370.386.700.250;E05.333.250
00000000|MMI|15.53|Negation|C1518422|[ftcn]|["Not"-tx-20-"not"-adv-0,"Not"-tx-19-"not"-adv-0,"Not"-tx-14-"NOT"-adv-0,"Not"-tx-8-"not"-adv-0]|TX|2882/3;2771/3;2166/3;1511/3|
00000000|MMI|14.90|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-60-"CAD"-noun-0,"CAD"-tx-12-"CAD"-noun-0,"CAD"-tx-1-"CAD"-noun-0]|TX|5673/3;[1932/3],[2036/3];65/3|
00000000|MMI|14.88|Hospital admission|C0184666|[hlca]|["admitted"-tx-43-"admitted"-verb-0,"Admission"-tx-14-"admission"-noun-0,"Admission"-tx-12-"Admission"-noun-0,"Admit"-tx-11-"ADMIT"-verb-0]|TX|4673/8;2459/9;1920/9;1815/5|
00000000|MMI|14.82|Today|C0310367|[antb,orch]|["Today"-tx-8-"Today"-noun-0,"Today"-tx-4-"Today"-noun-0]|TX|[1201/5],[1400/5];[530/5],[580/5]|
00000000|MMI|14.82|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-8-"Today"-noun-0,"Today"-tx-4-"Today"-noun-0]|TX|[1201/5],[1400/5];[530/5],[580/5]|
00000000|MMI|14.81|S prime|C2603362|[clna]|["S'"-tx-33-"S"-noun-0,"S'"-tx-12-"s"-prep-0,"S'"-tx-8-"("-noun-0,"S'"-tx-1-"s"-prep-0]|TX|3895/1;1938/1;1656/1;71/1|
00000000|MMI|14.81|per second|C0565930|[qnco]|["/s"-tx-33-"S"-noun-0,"/s"-tx-12-"s"-prep-0,"/s"-tx-8-"("-noun-0,"/s"-tx-1-"s"-prep-0]|TX|3895/1;1938/1;1656/1;71/1|
00000000|MMI|14.67|Peritoneal Cancer Index|C4049621|[inpr]|["PCI"-tx-49-"PCI"-noun-0,"PCI"-tx-13-"PCI"-noun-0,"PCI"-tx-12-"PCI"-noun-0,"PCI"-tx-1-"PCI"-noun-0]|TX|5042/3;2107/3;1942/3;75/3|
00000000|MMI|14.64|Diabetes Mellitus|C0011849|[dsyn]|["Diabetes"-tx-23-"DIABETES"-noun-0]|TX|3095/8|C18.452.394.750;C19.246
00000000|MMI|14.64|Endometriosis|C0014175|[dsyn]|["Endo"-tx-55-"Endo"-adj-0]|TX|5369/4|C13.351.500.163
00000000|MMI|14.64|Fever|C0015967|[fndg]|["Fevers"-tx-21-"fevers"-noun-1]|TX|2900/6|C23.888.119.344
00000000|MMI|14.64|Memory|C0025260|[menp]|["Memory"-tx-25-"memory"-noun-0]|TX|3315/6|F02.463.425.540
00000000|MMI|14.64|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-8-"PCP"-noun-0]|TX|1663/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|14.64|Telemetry|C0039451|[diap]|["Telemetry"-tx-55-"telemetry"-noun-0]|TX|5340/9|E01.370.520.750;E05.925;L01.178.847.675
00000000|MMI|14.64|clopidogrel|C0070166|[orch,phsu]|["CLOPIDOGREL"-tx-8-"CLOPIDOGREL"-noun-0]|TX|1225/11|x.x.x.x
00000000|MMI|14.61|Axial R|C3538806|[spco]|["Ra"-tx-37-"RA"-noun-0,"Ra"-tx-33-"RA"-noun-0,"Ra"-tx-22-"RA"-adj-0,"Ra"-tx-22-"RA"-noun-0]|TX|4350/2;3796/2;[2967/2],[3053/2];[2967/2],[3053/2]|
00000000|MMI|14.61|Right arm|C4048756|[bpoc]|["RA"-tx-37-"RA"-noun-0,"RA"-tx-33-"RA"-noun-0,"RA"-tx-22-"RA"-adj-0,"RA"-tx-22-"RA"-noun-0]|TX|4350/2;3796/2;[2967/2],[3053/2];[2967/2],[3053/2]|
00000000|MMI|14.33|Event Seriousness - Significant|C1546944|[qlco]|["Significant"-tx-48-"significant"-adj-0,"Significant"-tx-46-"significant"-adj-0,"Significant"-tx-41-"significant"-adj-0,"Significant"-tx-39-"significant"-adj-0]|TX|4958/11;4865/11;4507/11;4414/11|
00000000|MMI|14.33|Significant|C0750502|[idcn]|["Significant"-tx-48-"significant"-adj-0,"Significant"-tx-46-"significant"-adj-0,"Significant"-tx-41-"significant"-adj-0,"Significant"-tx-39-"significant"-adj-0]|TX|4958/11;4865/11;4507/11;4414/11|
00000000|MMI|14.33|Statistical Significance|C0237881|[qnco]|["significant"-tx-48-"significant"-adj-0,"significant"-tx-46-"significant"-adj-0,"significant"-tx-41-"significant"-adj-0,"significant"-tx-39-"significant"-adj-0]|TX|4958/11;4865/11;4507/11;4414/11|
00000000|MMI|14.28|50%|C3842586|[fndg]|["50%"-tx-48-"50"-percentage-1,"50%"-tx-41-"50"-percentage-1]|TX|[4992/2],[5030/2];[4541/2],[4579/2]|
00000000|MMI|14.28|<50|C3843766|[fndg]|["<50"-tx-48-"50"-percentage-1,"<50"-tx-41-"50"-percentage-1]|TX|[4992/2],[5030/2];[4541/2],[4579/2]|
00000000|MMI|13.24|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-4-"Home services"-noun-0]|TX|460/4,468/8|N04.452.758.307
00000000|MMI|13.14|Chest|C0817096|[blor]|["CHEST"-tx-33-"CHEST"-noun-0]|TX|3850/5|A01.923.761;A02.835.232.904
00000000|MMI|13.14|DSP protein, human|C1531217|[aapp,bacs]|["DP"-tx-33-"DP"-noun-0]|TX|3932/2|x.x.x.x
00000000|MMI|13.14|Ethanol|C0001962|[orch,phsu]|["ETOH"-tx-31-"EtOH"-noun-0]|TX|3703/4|D02.033.375;x.x.x.x
00000000|MMI|13.14|Rest|C0035253|[dora]|["Rest"-tx-15-"rest"-noun-0]|TX|2517/4|I03.450.769.647
00000000|MMI|13.10|Secondary Prevention|C0679699|[topp]|["SECONDARY PREVENTION"-tx-60-"Secondary prevention"-noun-0]|TX|5649/20|E02.897;N02.421.726.825;N06.850.780.750
00000000|MMI|13.09|Biomechanical compliance|C0009563|[qnco]|["Compliance"-tx-14-"compliance"-noun-0]|TX|2335/10|G01.374.590.210
00000000|MMI|13.09|Compliance|C3714738|[fndg]|["Compliance"-tx-14-"compliance"-noun-0]|TX|2335/10|G01.374.590.210
00000000|MMI|13.09|Diarrhea|C0011991|[sosy]|["DIARRHOEA"-tx-21-"diarrhea"-noun-1]|TX|2922/8|C23.888.821.214
00000000|MMI|13.09|Paraguay|C0030428|[geoa]|["PA"-tx-37-"PA"-noun-0]|TX|4365/2|Z01.107.757.656
00000000|MMI|13.09|Solomon Islands|C0037623|[geoa]|["BP"-tx-22-"BP"-noun-0]|TX|2946/2|Z01.639.760.590
00000000|MMI|13.02|Cardiology discipline|C0007189|[bmod]|["Cardiology"-tx-8-"Cardiology"-noun-0]|TX|1703/10|H02.403.429.163
00000000|MMI|13.00|Diet|C0012155|[food]|["Diet"-tx-8-"DIET"-noun-0]|TX|1565/4|G07.203.650.240
00000000|MMI|13.00|Oral cavity|C0226896|[bsoj]|["MOUTH"-tx-8-"mouth"-noun-0]|TX|1534/5|A01.456.505.631;A03.556.500;A14.549
00000000|MMI|13.00|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|335/3|E04.157.310;E04.950.300.299
00000000|MMI|12.95|O-beta-ribosyl(1''--2')adenosine-5''-phosphate|C0643319|[nnon]|["R-AMP"-tx-34-"R amp"-noun-0]|TX|4143/1,4146/3|x.x.x.x
00000000|MMI|12.94|Nausea|C0027497|[sosy]|["NAUSEA"-tx-16-"nausea"-noun-1]|TX|2564/6|C23.888.821.712
00000000|MMI|12.93|Bolivia|C0005918|[geoa]|["BL"-tx-33-"BL"-noun-0]|TX|3861/2|Z01.107.757.136
00000000|MMI|12.91|Acute fatty liver of pregnancy|C1455728|[dsyn]|["Fatty liver of pregnancy"-tx-23-"FATTY LIVER OF PREGNANCY"-noun-0]|TX|3117/11,3142/12|x.x.x.x
00000000|MMI|12.90|Panama|C0030266|[geoa]|["PM"-tx-1-"PM"-adj-0]|TX|296/2|Z01.107.169.772
00000000|MMI|12.89|Coughing|C0010200|[sosy]|["COUGH"-tx-20-"cough"-noun-0]|TX|2855/5|C08.618.248;C23.888.852.293
00000000|MMI|12.89|Rales|C0034642|[sosy]|["RALES"-tx-22-"rales"-noun-0]|TX|2985/5|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|12.88|1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride|C0057472|[orch,phsu]|["DEP"-tx-23-"DEP"-noun-0]|TX|3110/3|x.x.x.x
00000000|MMI|11.49|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|1802/7|H02.403.044
00000000|MMI|11.49|Chills|C0085593|[sosy]|["CHILLS"-tx-21-"chills"-noun-1]|TX|2909/6|C23.888.208
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-12-"Complications"-noun-0]|TX|1995/13|x.x.x
00000000|MMI|11.49|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-14-"HTN"-noun-0]|TX|2309/3|C14.907.489
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-12-"PROCEDURES"-noun-0]|TX|2055/10|x.x.x
00000000|MMI|11.49|utilization qualifier|C0042153|[ftcn]|["use"-tx-18-"uses"-verb-0]|TX|2729/4|x.x.x
00000000|MMI|11.42|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-59-"DM"-noun-0,"DM"-tx-55-"DM"-noun-0,"DM"-tx-14-"DM"-noun-0]|TX|5637/2;5375/2;2315/2|
00000000|MMI|11.35|PSMD2 gene|C1419032|[gngm]|["S2"-tx-47-"S2"-noun-0,"S2"-tx-40-"S2"-noun-0,"S2"-tx-33-"S2"-noun-0]|TX|4951/2;4500/2;3876/2|
00000000|MMI|11.35|RPS2 gene|C1419718|[gngm]|["S2"-tx-47-"S2"-noun-0,"S2"-tx-40-"S2"-noun-0,"S2"-tx-33-"S2"-noun-0]|TX|4951/2;4500/2;3876/2|
00000000|MMI|11.35|S2|C3812876|[fndg]|["S2"-tx-47-"S2"-noun-0,"S2"-tx-40-"S2"-noun-0,"S2"-tx-33-"S2"-noun-0]|TX|4951/2;4500/2;3876/2|
00000000|MMI|11.35|S2 innervation|C1179705|[blor]|["S2"-tx-47-"S2"-noun-0,"S2"-tx-40-"S2"-noun-0,"S2"-tx-33-"S2"-noun-0]|TX|4951/2;4500/2;3876/2|
00000000|MMI|11.35|Testicular Cancer Serum Markers Test Result S2|C3812875|[lbtr]|["S2"-tx-47-"S2"-noun-0,"S2"-tx-40-"S2"-noun-0,"S2"-tx-33-"S2"-noun-0]|TX|4951/2;4500/2;3876/2|
00000000|MMI|11.02|65|C0450385|[inpr]|["65"-tx-54-"65"-percentage-0,"65"-tx-23-"65"-percentage-0,"65"-tx-1-"65"-integer-0]|TX|5328/2;3214/2;222/2|
00000000|MMI|11.02|65+|C3843765|[fndg]|["65+"-tx-54-"65"-percentage-0,"65+"-tx-23-"65"-percentage-0,"65+"-tx-1-"65"-integer-0]|TX|5328/2;3214/2;222/2|
00000000|MMI|10.92|Code|C0805701|[inpr]|["CODE"-tx-59-"Code"-noun-0,"CODE"-tx-4-"CODE"-noun-0,"CODE"-tx-4-"code"-noun-0]|TX|5556/4;424/4;442/4|
00000000|MMI|10.92|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-59-"Code"-noun-0,"Code"-tx-4-"CODE"-noun-0,"Code"-tx-4-"code"-noun-0]|TX|5556/4;424/4;442/4|
00000000|MMI|10.86|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-58-"3"-integer-0,"3+"-tx-23-"3"-fraction-0,"3+"-tx-1-"3"-fraction-0]|TX|5475/1;3203/1;112/1|
00000000|MMI|10.86|3+ Score|C2827736|[qnco]|["3+"-tx-58-"3"-integer-0,"3+"-tx-23-"3"-fraction-0,"3+"-tx-1-"3"-fraction-0]|TX|5475/1;3203/1;112/1|
00000000|MMI|10.86|3+ Score, WHO|C2981702|[clas]|["3+"-tx-58-"3"-integer-0,"3+"-tx-23-"3"-fraction-0,"3+"-tx-1-"3"-fraction-0]|TX|5475/1;3203/1;112/1|
00000000|MMI|10.86|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-58-"3"-integer-0,"<3"-tx-23-"3"-fraction-0,"<3"-tx-1-"3"-fraction-0]|TX|5475/1;3203/1;112/1|
00000000|MMI|10.80|Admission activity|C0809949|[hlca]|["Admitted"-tx-43-"admitted"-verb-0,"Admission"-tx-14-"admission"-noun-0,"Admission"-tx-12-"Admission"-noun-0]|TX|4673/8;2459/9;1920/9|
00000000|MMI|10.70|70%|C3842584|[fndg]|["70%"-tx-47-"70"-percentage-0,"70%"-tx-40-"70"-percentage-0,"70%"-tx-33-"70s"-noun-0]|TX|4897/2;4446/2;3787/3|
00000000|MMI|10.53|Unit|C0439148|[qnco]|["UNITS"-tx-26-"UNITS"-noun-0,"UNITS"-tx-8-"UNITS"-noun-0]|TX|3364/5;[1374/5],[1490/5]|
00000000|MMI|10.53|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-26-"UNITS"-noun-0,"Units"-tx-8-"UNITS"-noun-0]|TX|3364/5;[1374/5],[1490/5]|
00000000|MMI|10.53|Unit of Measure|C1519795|[qnco]|["Units"-tx-26-"UNITS"-noun-0,"Units"-tx-8-"UNITS"-noun-0]|TX|3364/5;[1374/5],[1490/5]|
00000000|MMI|10.42|Deny (action)|C2700401|[acty]|["Deny"-tx-18-"denies"-verb-0,"Denied"-tx-16-"Denied"-verb-0]|TX|2755/6;2546/6|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-12-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-11-"DIAGNOSIS"-noun-0]|TX|1959/9;1821/9|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-12-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-11-"DIAGNOSIS"-noun-0]|TX|1959/9;1821/9|
00000000|MMI|10.42|Give - dosing instruction imperative|C1947971|[ftcn]|["Given"-tx-22-"given"-verb-0,"Give"-tx-8-"give"-verb-0]|TX|3028/5;1429/4|
00000000|MMI|10.42|Hold (action)|C1948035|[acty]|["Hold"-tx-8-"HOLD"-verb-0]|TX|[1128/4],[1502/4]|
00000000|MMI|10.42|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-8-"HOLD"-verb-0]|TX|[1128/4],[1502/4]|
00000000|MMI|10.42|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-8-"Instructions"-noun-0]|TX|[1281/12],[1415/12]|
00000000|MMI|10.42|Instructions|C1442085|[idcn]|["Instructions"-tx-8-"Instructions"-noun-0]|TX|[1281/12],[1415/12]|
00000000|MMI|10.42|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-8-"Instructions"-noun-0]|TX|[1281/12],[1415/12]|
00000000|MMI|10.42|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-26-"MEDS"-noun-0,"MEDS"-tx-19-"meds"-noun-1]|TX|3348/4;2831/4|
00000000|MMI|10.42|Pharmaceutical Preparations|C0013227|[phsu]|["Drugs"-tx-32-"drugs"-noun-0,"Medications"-tx-4-"MEDICATIONS"-noun-0]|TX|3712/5;487/11|D26
00000000|MMI|10.42|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-43-"Pt"-noun-0,"PT"-tx-17-"pt"-noun-0]|TX|4670/2;2589/2|
00000000|MMI|10.42|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-43-"Pt"-noun-0,"PT"-tx-17-"pt"-noun-0]|TX|4670/2;2589/2|
00000000|MMI|10.42|Plavix|C0633084|[orch,phsu]|["Plavix"-tx-51-"plavix"-noun-0,"Plavix"-tx-8-"PLAVIX"-noun-0]|TX|5115/6;1216/6|
00000000|MMI|10.42|Positive|C1446409|[qlco]|["ruled"-tx-44-"Ruled"-verb-0,"ruled"-tx-44-"ruled"-verb-0]|TX|4731/5;4721/5|
00000000|MMI|10.42|To|C1883351|[qlco]|["To"-tx-10-"to"-adv-0,"To"-tx-8-"to"-adv-0]|TX|1769/2;1325/2|
00000000|MMI|10.42|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-8-"HOLD"-verb-0]|TX|[1128/4],[1502/4]|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-62-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5797/6;187/6|
00000000|MMI|9.99|Abdomen|C0000726|[blor]|["abd"-tx-33-"ABD"-noun-0]|TX|3890/3|A01.923.047
00000000|MMI|9.99|Stent, device|C0038257|[medd]|["stenting"-tx-49-"stenting"-noun-0]|TX|5065/8|E07.695.750
00000000|MMI|9.96|Fatty Liver|C0015695|[dsyn]|["FATTY LIVER"-tx-34-"fatty liver"-noun-1]|TX|4162/11|C06.552.241
00000000|MMI|9.96|Steatohepatitis|C2711227|[dsyn]|["Fatty liver"-tx-34-"fatty liver"-noun-1]|TX|4162/11|C06.552.241
00000000|MMI|9.94|Neurology speciality|C0027855|[bmod]|["NEURO"-tx-33-"NEURO"-adj-0]|TX|3971/5|H02.403.600
00000000|MMI|9.91|Pressure- physical agent|C0033095|[phpr]|["Pressures"-tx-37-"pressures"-noun-0]|TX|4339/9|G01.374.715
00000000|MMI|9.91|Child|C0008059|[aggp]|["Children"-tx-28-"children"-noun-0]|TX|3620/8|M01.060.406
00000000|MMI|9.91|Netherlands|C0027778|[geoa]|["NL"-tx-24-"nl"-noun-0]|TX|3243/2|Z01.542.651
00000000|MMI|9.90|Beds|C0004916|[mnob]|["Bed"-tx-17-"bed"-noun-0]|TX|2604/3|E07.325.220
00000000|MMI|9.90|Physical Examination|C0031809|[hlca]|["PHYSICAL EXAM"-tx-33-"PHYSICAL EXAM"-noun-0]|TX|3744/13|E01.370.600
00000000|MMI|9.87|Outpatients|C0029921|[podg]|["Outpatient"-tx-57-"outpatient"-noun-0]|TX|5455/10|M01.643.630
00000000|MMI|9.87|enzymology|C0014445|[ftcn]|["enzymes"-tx-44-"enzymes"-noun-0]|TX|4744/7|x.x.x
00000000|MMI|9.85|Diet therapy|C0012159|[hlca]|["Diet"-tx-8-"DIET"-noun-0]|TX|1565/4|E02.642.249
00000000|MMI|9.84|Pancreatitis|C0030305|[dsyn]|["PANCREATITIS"-tx-23-"PANCREATITIS"-noun-0]|TX|3129/12|C06.689.750
00000000|MMI|9.78|Nonprofit Organizations|C0029247|[orgt]|["NPO"-tx-8-"npo"-noun-0]|TX|1448/3|N03.540.630
00000000|MMI|9.78|Social Interaction|C0037420|[fndg]|["Social Interactions"-tx-28-"social interactions"-noun-0]|TX|3597/19|F01.829.401
00000000|MMI|9.76|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-8-"TAB"-noun-0]|TX|1096/3|D26.255.830
00000000|MMI|9.74|Universities|C0041740|[mnob,orgt]|["University"-tx-8-"University"-noun-0]|TX|1724/10|I02.783.830
00000000|MMI|8.34|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|1802/7|C20.543
00000000|MMI|8.34|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-11-"ALLERGY"-noun-0]|TX|1802/7|C20.543
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-12-"Infections"-noun-0]|TX|1982/10|C01.539
00000000|MMI|8.28|Show|C1547282|[anim]|["Show"-tx-54-"shows"-verb-0,"Show"-tx-45-"showing"-verb-0]|TX|5310/5;4835/7|
00000000|MMI|8.28|Take|C1515187|[hlca]|["Take"-tx-8-"Take"-verb-0,"Take"-tx-8-"taking"-verb-0]|TX|1295/4;1515/6|
00000000|MMI|7.70|Admission Level of Care Code - Improved|C1561611|[inpr]|["Improved"-tx-17-"improved"-adj-0,"Improved"-tx-15-"improved"-verb-0]|TX|2681/8;2505/8|
00000000|MMI|7.70|Better|C0332272|[qlco]|["Improved"-tx-17-"improved"-adj-0,"Improved"-tx-15-"improved"-verb-0]|TX|2681/8;2505/8|
00000000|MMI|7.70|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-34-"gt"-noun-0,"GT"-tx-22-"gt"-noun-0]|TX|4140/2;3037/2|
00000000|MMI|7.70|Improved|C0184511|[qlco]|["Improved"-tx-17-"improved"-adj-0,"Improved"-tx-15-"improved"-verb-0]|TX|2681/8;2505/8|
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-59-"CONDITION"-noun-0,"Condition"-tx-12-"Conditions"-noun-0]|TX|5598/9;1969/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-59-"CONDITION"-noun-0,"Condition"-tx-12-"Conditions"-noun-0]|TX|5598/9;1969/10|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-59-"CONDITION"-noun-0,"Condition"-tx-12-"Conditions"-noun-0]|TX|5598/9;1969/10|
00000000|MMI|7.57|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-42-"CV"-noun-0,"CV"-tx-33-"CV"-noun-0]|TX|4656/2;3869/2|
00000000|MMI|7.56|Chest pain:Finding:Point in time:^Patient:Ordinal|C2926613|[clna]|["Chest pain"-tx-14-"chest pain"-noun-0,"Chest pain"-tx-8-"chest pain"-noun-0]|TX|2222/10;1117/10|
00000000|MMI|7.53|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-62-"END"-noun-0,"Stop"-tx-8-"stop"-verb-0]|TX|5780/3;1328/4|
00000000|MMI|7.49|Echo (insect)|C1655045|[euka]|["Echo"-tx-54-"Echo"-noun-0,"Echo"-tx-23-"echo"-verb-0]|TX|5295/4;3198/4|
00000000|MMI|7.47|Out (direction)|C0439787|[spco]|["Out"-tx-44-"out"-adv-0]|TX|[4727/3],[4737/3]|
00000000|MMI|7.47|Removed|C0849355|[qlco]|["Out"-tx-44-"out"-adv-0]|TX|[4727/3],[4737/3]|
00000000|MMI|7.40|ALYREF gene|C1425988|[gngm]|["REF"-tx-8-"ref"-noun-0,"REF"-tx-7-"ref"-noun-0]|TX|949/3;714/3|
00000000|MMI|7.33|Planned|C1301732|[ftcn]|["Plan"-tx-59-"PLAN"-noun-0,"Plan"-tx-42-"PLAN"-noun-0]|TX|5622/4;4647/4|
00000000|MMI|7.33|Treatment Plan|C0599880|[inpr]|["Plan"-tx-59-"PLAN"-noun-0,"Plan"-tx-42-"PLAN"-noun-0]|TX|5622/4;4647/4|
00000000|MMI|7.31|Accident caused by unspecified fire|C0000912|[phpr]|["Burning NOS"-tx-17-"burning"-noun-0,"Burning NOS"-tx-14-"burning"-noun-0]|TX|2664/7;2396/7|
00000000|MMI|7.31|Burning sensation|C0085624|[sosy]|["Burning"-tx-17-"burning"-noun-0,"Burning"-tx-14-"burning"-noun-0]|TX|2664/7;2396/7|
00000000|MMI|7.31|Burning sensation quality|C0175627|[qlco]|["Burning"-tx-17-"burning"-noun-0,"Burning"-tx-14-"burning"-noun-0]|TX|2664/7;2396/7|
00000000|MMI|7.31|C-Circle|C3538933|[celc]|["CC"-tx-22-"cc"-noun-0,"CC"-tx-14-"CC"-noun-0]|TX|3044/2;2218/2|
00000000|MMI|7.31|Device Component System|C1704459|[mnob]|["System"-tx-45-"system"-noun-0,"System"-tx-38-"system"-noun-0]|TX|4854/6;4403/6|
00000000|MMI|7.31|Interaction|C1704675|[ftcn]|["Interaction"-tx-8-"INTERACTION"-noun-0,"Interaction"-tx-7-"INTERACTION"-noun-0]|TX|987/11;752/11|
00000000|MMI|7.31|System|C0449913|[ftcn]|["System"-tx-45-"system"-noun-0,"System"-tx-38-"system"-noun-0]|TX|4854/6;4403/6|
00000000|MMI|7.31|System - kit|C1553451|[mnob]|["System"-tx-45-"system"-noun-0,"System"-tx-38-"system"-noun-0]|TX|4854/6;4403/6|
00000000|MMI|7.28|/40|C0439509|[tmco]|["/40"-tx-8-"40"-integer-0]|TX|[1175/2],[1695/2]|
00000000|MMI|7.28|40%|C3842587|[qnco]|["40%"-tx-8-"40"-integer-0]|TX|[1175/2],[1695/2]|
00000000|MMI|7.28|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-59-"regimen"-noun-0,"regimen"-tx-57-"regimen"-noun-0]|TX|5640/7;5412/7|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-61-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|5690/7;364/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-61-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|5690/7;364/7|
00000000|MMI|7.25|Night time|C0240526|[tmco]|["Night"-tx-18-"night"-noun-0,"Night"-tx-17-"night"-noun-0]|TX|2747/5;2616/5|
00000000|MMI|7.21|Medical History|C0262926|[fndg]|["Hx"-tx-23-"HX"-noun-0,"PMH"-tx-23-"PMH"-noun-0]|TX|3114/2;3090/3|
00000000|MMI|7.19|Current (present time)|C0521116|[tmco]|["Currently"-tx-53-"currently"-adv-0,"Currently"-tx-20-"currently"-adv-0]|TX|5243/9;2886/9|
00000000|MMI|7.18|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-8-"Reason"-noun-0,"Reason"-tx-7-"Reason"-noun-0]|TX|1036/6;801/6|
00000000|MMI|7.16|Worse|C1457868|[fndg]|["Worse"-tx-17-"worse"-adj-0,"Worsened"-tx-15-"worsened"-adj-0]|TX|2643/5;2524/8|
00000000|MMI|7.16|Additional|C1524062|[ftcn]|["Added"-tx-7-"added"-verb-0,"Added"-tx-4-"added"-verb-0]|TX|868/5;621/5|
00000000|MMI|7.15|Shortened|C1282927|[qlco]|["brief"-tx-14-"BRIEF"-adj-0,"short"-tx-11-"Shortness"-noun-0]|TX|2185/5;1832/9|
00000000|MMI|7.14|Cancer/Testis Antigen|C3813556|[aapp]|["CT"-tx-34-"CT"-noun-0,"CTA"-tx-33-"CTA"-noun-0]|TX|4056/2;3857/3|
00000000|MMI|7.14|PCYT1A wt Allele|C3540513|[gngm]|["CT"-tx-34-"CT"-noun-0,"CTA"-tx-33-"CTA"-noun-0]|TX|4056/2;3857/3|
00000000|MMI|7.13|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-51-"ASA"-noun-0,"ASA"-tx-26-"Asa"-noun-0]|TX|5109/3;3449/3|
00000000|MMI|7.13|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-33-"edema"-noun-0,"Edema"-tx-20-"edema"-noun-0]|TX|3917/5;2870/5|
00000000|MMI|7.10|Hospital course|C0489547|[fndg]|["Hospital course"-tx-42-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-14-"HOSPITAL COURSE"-noun-1]|TX|4616/15;2201/15|
00000000|MMI|7.10|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-42-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-14-"HOSPITAL COURSE"-noun-0]|TX|4616/15;2201/15|
00000000|MMI|7.10|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-22-"sat"-noun-0,"SAT"-tx-8-"sat"-noun-0]|TX|3056/3;1592/3|
00000000|MMI|7.10|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-22-"sat"-noun-0,"SAT"-tx-8-"sat"-noun-0]|TX|3056/3;1592/3|
00000000|MMI|7.09|Mild (qualifier value)|C2945599|[qlco]|["MILD"-tx-54-"mild"-adj-0,"MILD"-tx-24-"Mild"-adj-0]|TX|5316/4;3219/4|
00000000|MMI|7.09|LDB3 gene|C1423674|[gngm]|["CYPHER"-tx-49-"cypher"-noun-0,"CYPHER"-tx-13-"Cypher"-noun-0]|TX|5058/6;2113/6|
00000000|MMI|7.07|10%|C3842590|[fndg]|["10%"-tx-45-"10"-fraction-0,"10%"-tx-1-"10"-fraction-0]|TX|4832/2;153/2|
00000000|MMI|7.06|Conditional|C1701901|[qlco]|["Dependent"-tx-34-"dependent"-adj-0,"Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|4150/9;299/10|
00000000|MMI|7.04|Subject Continuance|C2826258|[evnt]|["CONT"-tx-53-"cont"-noun-0,"CONT"-tx-51-"Cont"-noun-0]|TX|5264/4;5104/4|
00000000|MMI|7.04|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-14-"RESUME"-noun-0,"Resume"-tx-8-"Resume"-noun-0]|TX|2191/6;1611/6|
00000000|MMI|7.04|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-14-"RESUME"-noun-0,"Resume"-tx-8-"Resume"-noun-0]|TX|2191/6;1611/6|
00000000|MMI|7.04|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-14-"RESUME"-noun-0,"resume"-tx-8-"Resume"-noun-0]|TX|2191/6;1611/6|
00000000|MMI|7.03|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-58-"obesity"-noun-0,"Obesity"-tx-23-"OBESITY"-noun-0]|TX|5501/7;3170/7|
00000000|MMI|6.99|Dominant|C1527180|[ftcn]|["Dominant"-tx-45-"dominant"-adj-0,"Dominant"-tx-38-"dominant"-adj-0]|TX|4845/8;4394/8|
00000000|MMI|6.99|Full|C0443225|[qlco]|["Full"-tx-59-"FULL"-adj-0,"Full"-tx-4-"Full"-adj-0]|TX|5562/4;437/4|
00000000|MMI|6.99|Left coronary artery structure|C1261082|[bpoc]|["LM"-tx-46-"LM"-noun-0,"LM"-tx-39-"LM"-noun-0]|TX|4877/2;4426/2|
00000000|MMI|6.99|Methylcytosine Dioxygenase TET1|C2987138|[aapp,enzy]|["LCX"-tx-48-"LCx"-noun-0,"LCX"-tx-41-"LCx"-noun-0]|TX|4970/3;4519/3|
00000000|MMI|6.99|Serious|C0205404|[qlco]|["Serious"-tx-8-"SERIOUS"-adj-0,"Serious"-tx-7-"SERIOUS"-adj-0]|TX|979/7;744/7|
00000000|MMI|6.99|TET1 gene|C1428863|[gngm]|["LCX"-tx-48-"LCx"-noun-0,"LCX"-tx-41-"LCx"-noun-0]|TX|4970/3;4519/3|
00000000|MMI|6.99|TET1 wt Allele|C2987137|[gngm]|["LCX"-tx-48-"LCx"-noun-0,"LCX"-tx-41-"LCx"-noun-0]|TX|4970/3;4519/3|
00000000|MMI|6.99|Units Of Measure - lumen|C1551056|[qnco]|["lm"-tx-46-"LM"-noun-0,"lm"-tx-39-"LM"-noun-0]|TX|4877/2;4426/2|
00000000|MMI|6.99|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-1,"DIS"-tx-1-"DIS"-noun-0]|TX|335/3;90/3|
00000000|MMI|6.97|0%|C3842591|[fndg]|["0%"-tx-8-"0"-real_number-0,"0%"-tx-1-"0"-integer-0]|TX|1085/1;228/1|
00000000|MMI|6.95|Bedtime (qualifier value)|C0521112|[tmco]|["Bedtime"-tx-8-"BEDTIME"-noun-0]|TX|[1184/7],[1383/7]|
00000000|MMI|6.94|60%|C3842585|[fndg]|["60%"-tx-26-"60"-integer-0,"60%"-tx-8-"60"-integer-0]|TX|3361/2;1371/2|
00000000|MMI|6.92|Gait normal|C0231683|[fndg]|["Normal"-tx-37-"normal"-adj-0,"Normal"-tx-25-"normal"-adj-0]|TX|4312/6;3299/6|
00000000|MMI|6.92|Mean Percent of Normal|C2347086|[qnco]|["% Normal"-tx-37-"normal"-adj-0,"% Normal"-tx-25-"normal"-adj-0]|TX|4312/6;3299/6|
00000000|MMI|6.92|Normal|C0205307|[qlco]|["NORMAL"-tx-37-"normal"-adj-0,"NORMAL"-tx-25-"normal"-adj-0]|TX|4312/6;3299/6|
00000000|MMI|6.92|Percent normal|C0439166|[qnco]|["% normal"-tx-37-"normal"-adj-0,"% normal"-tx-25-"normal"-adj-0]|TX|4312/6;3299/6|
00000000|MMI|6.91|Depressed mood|C0344315|[fndg]|["depression"-tx-28-"depression"-noun-0,"depression"-tx-23-"DEPRESSION"-noun-0]|TX|3649/10;3159/10|
00000000|MMI|6.91|Depression Scale (BASC-2)|C4049644|[inpr]|["Depression"-tx-28-"depression"-noun-0,"Depression"-tx-23-"DEPRESSION"-noun-0]|TX|3649/10;3159/10|
00000000|MMI|6.91|Depression motion|C0460137|[ftcn]|["Depression"-tx-28-"depression"-noun-0,"Depression"-tx-23-"DEPRESSION"-noun-0]|TX|3649/10;3159/10|
00000000|MMI|6.90|Tubular formation|C0332208|[spco]|["Tubular"-tx-48-"tubular"-adj-0,"Tubular"-tx-41-"tubular"-adj-0]|TX|4984/7;4533/7|
00000000|MMI|6.89|Borg Category-Ratio 10 Perceived Exertion Score 3|C4049706|[inpr]|["Moderate"-tx-44-"moderate"-adj-0,"Moderate"-tx-36-"moderate"-adj-0]|TX|4771/8;4265/8|
00000000|MMI|6.89|Geographic state|C1301808|[geoa]|["Territory"-tx-44-"territory"-noun-0,"Territory"-tx-36-"territory"-noun-0]|TX|4799/9;4293/9|
00000000|MMI|6.89|Moderate (severity modifier)|C0205081|[qlco]|["Moderate"-tx-44-"moderate"-adj-0,"Moderate"-tx-36-"moderate"-adj-0]|TX|4771/8;4265/8|
00000000|MMI|6.89|Moderate Extremity Pain|C4049705|[inpr]|["Moderate"-tx-44-"moderate"-adj-0,"Moderate"-tx-36-"moderate"-adj-0]|TX|4771/8;4265/8|
00000000|MMI|6.89|Moderation|C1881878|[qlco]|["MODERATE"-tx-44-"moderate"-adj-0,"MODERATE"-tx-36-"moderate"-adj-0]|TX|4771/8;4265/8|
00000000|MMI|6.89|Territory|C2983136|[geoa]|["Territory"-tx-44-"territory"-noun-0,"Territory"-tx-36-"territory"-noun-0]|TX|4799/9;4293/9|
00000000|MMI|6.88|Serum lipids high (finding)|C0428465|[fndg]|["Hyperlipidemia"-tx-23-"HYPERLIPIDEMIA"-noun-0,"Hyperlipidemia"-tx-14-"hyperlipidemia"-noun-0]|TX|3178/14;2292/14|
00000000|MMI|6.88|90%|C3842582|[fndg]|["90%"-tx-47-"90"-percentage-0,"90%"-tx-40-"90"-percentage-0]|TX|4932/2;4481/2|
00000000|MMI|6.88|<90|C0439087|[qnco]|["<90"-tx-47-"90"-percentage-0,"<90"-tx-40-"90"-percentage-0]|TX|4932/2;4481/2|
00000000|MMI|6.88|>90|C0439083|[qnco]|[">90"-tx-47-"90"-percentage-0,">90"-tx-40-"90"-percentage-0]|TX|4932/2;4481/2|
00000000|MMI|6.88|Focal|C0205234|[spco]|["FOCAL"-tx-47-"focal"-adj-0,"FOCAL"-tx-40-"focal"-adj-0]|TX|4926/5;4475/5|
00000000|MMI|6.88|PDHX gene|C1427500|[gngm]|["proX"-tx-47-"prox"-noun-0,"proX"-tx-40-"prox"-noun-0]|TX|4901/4;4450/4|
00000000|MMI|6.88|Stenosis (invertebrate)|C2632116|[euka]|["Stenosis"-tx-47-"stenosis"-noun-0,"Stenosis"-tx-40-"stenosis"-noun-0]|TX|4936/8;4485/8|
00000000|MMI|6.88|Stenosis Morphology|C0678234|[qlco]|["Stenosis"-tx-47-"stenosis"-noun-0,"Stenosis"-tx-40-"stenosis"-noun-0]|TX|4936/8;4485/8|
00000000|MMI|6.83|pH|C4048290|[qnco]|["pH"-tx-3-"PH"-noun-0]|TX|420/2|G02.300
00000000|MMI|6.71|Enzymes|C0014442|[enzy,orch]|["ENZYMES"-tx-44-"enzymes"-noun-0]|TX|4744/7|D08.811
00000000|MMI|6.71|Minor (person)|C0026193|[popg]|["Minor"-tx-35-"minor"-adj-0]|TX|4234/5|M01.416
00000000|MMI|6.71|Work|C0043227|[ocac]|["works"-tx-26-"Works"-noun-0]|TX|3532/5|I03.946
00000000|MMI|6.70|Woman|C0043210|[popg]|["WOMAN"-tx-14-"woman"-noun-0]|TX|2277/5|M01.975
00000000|MMI|6.62|Alkalies|C0002055|[inch]|["base"-tx-33-"base"-noun-0]|TX|3864/4|D01.045
00000000|MMI|6.59|Heart|C0018787|[bpoc]|["Cardiac"-tx-45-"cardiac"-adj-0]|TX|4814/7|A07.541
00000000|MMI|5.18|+5|C0728893|[qnco]|["+5"-tx-59-"5"-integer-0]|TX|5552/1|
00000000|MMI|5.18|>5|C0439084|[qnco]|[">5"-tx-59-"5"-integer-0]|TX|5552/1|
00000000|MMI|5.18|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|244/7|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-12-"affecting"-verb-0]|TX|2011/9|
00000000|MMI|5.18|All|C0444868|[qnco]|["ALL"-tx-26-"ALL"-noun-0]|TX|3490/3|
00000000|MMI|5.18|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|1802/7|
00000000|MMI|5.18|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|1802/7|
00000000|MMI|5.18|Breath|C0225386|[bdsu]|["Breath"-tx-11-"breath"-noun-0]|TX|1845/6|
00000000|MMI|5.18|Clinical Trial Final Report|C3889645|[inpr]|["Reports"-tx-25-"Reports"-noun-0]|TX|3247/7|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-12-"Complications"-noun-0]|TX|1995/13|
00000000|MMI|5.18|DRUGS|C3687832|[topp]|["DRUGS"-tx-32-"drugs"-noun-0]|TX|3712/5|
00000000|MMI|5.18|Data Validation Test Document|C3899446|[inpr]|["DVT"-tx-34-"DVT"-noun-0]|TX|4068/3|
00000000|MMI|5.18|Denied (qualifier)|C0332319|[qlco]|["Denied"-tx-16-"Denied"-verb-0]|TX|2546/6|
00000000|MMI|5.18|Diabetes|C0011847|[dsyn]|["Diabetes"-tx-23-"DIABETES"-noun-0]|TX|3095/8|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|137/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|137/14|
00000000|MMI|5.18|Entity Name Part Type - given|C1550718|[idcn]|["given"-tx-22-"given"-verb-0]|TX|3028/5|
00000000|MMI|5.18|Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal|C2926618|[clna]|["DVT"-tx-34-"DVT"-noun-0]|TX|4068/3|
00000000|MMI|5.18|GIVEN|C1442162|[cnce]|["GIVEN"-tx-22-"given"-verb-0]|TX|3028/5|
00000000|MMI|5.18|GORAB gene|C1822658|[gngm]|["GO"-tx-1-"Go"-verb-0]|TX|241/2|
00000000|MMI|5.18|Given name|C3244317|[inpr]|["given"-tx-22-"given"-verb-0]|TX|3028/5|
00000000|MMI|5.18|Information|C1533716|[idcn]|["INFORMATION"-tx-7-"information"-noun-0]|TX|846/11|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-12-"PROCEDURES"-noun-0]|TX|2055/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-12-"affecting"-verb-0]|TX|2011/9|
00000000|MMI|5.18|Last|C1517741|[qlco]|["Last"-tx-23-"Last"-adj-0]|TX|3193/4|
00000000|MMI|5.18|Left atrial hypertrophy|C0238705|[anab]|["LAE"-tx-35-"LAE"-noun-0]|TX|4252/3|
00000000|MMI|5.18|MANEA gene|C1427293|[gngm]|["ENDO"-tx-55-"Endo"-adj-0]|TX|5369/4|
00000000|MMI|5.18|Make - Instruction Imperative|C1881534|[ftcn]|["Make"-tx-10-"make"-verb-0]|TX|1772/4|
00000000|MMI|5.18|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-4-"MEDICATIONS"-noun-0]|TX|487/11|
00000000|MMI|5.18|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-4-"MEDICATIONS"-noun-0]|TX|487/11|
00000000|MMI|5.18|Memory Device Component|C1706377|[mnob]|["Memory"-tx-25-"memory"-noun-0]|TX|3315/6|
00000000|MMI|5.18|Memory observations|C0700327|[fndg]|["memory"-tx-25-"memory"-noun-0]|TX|3315/6|
00000000|MMI|5.18|NPPA gene|C1417807|[gngm]|["PND"-tx-18-"PND"-noun-0]|TX|2762/3|
00000000|MMI|5.18|Never smoked tobacco|C0425293|[fndg]|["Non-Smoker"-tx-30-"Nonsmoker"-noun-0]|TX|3687/9|
00000000|MMI|5.18|Non-smoker|C0337672|[fndg]|["nonsmoker"-tx-30-"Nonsmoker"-noun-0]|TX|3687/9|
00000000|MMI|5.18|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|315/14|
00000000|MMI|5.18|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-53-"p"-noun-0]|TX|5238/1|
00000000|MMI|5.18|P prime|C2603361|[clna]|["P'"-tx-53-"p"-noun-0]|TX|5238/1|
00000000|MMI|5.18|PPP4C gene|C1418850|[gngm]|["PPX"-tx-58-"PPX"-noun-0]|TX|5524/3|
00000000|MMI|5.18|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|315/14|
00000000|MMI|5.18|Paroxysmal nocturnal dyspnea|C1956415|[dsyn]|["PND"-tx-18-"PND"-noun-1]|TX|2762/3|
00000000|MMI|5.18|Physiologic pulse|C0391850|[phsf]|["Pulse"-tx-33-"pulses"-verb-1]|TX|3935/6|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-12-"PROCEDURES"-noun-0]|TX|2055/10|
00000000|MMI|5.18|Pulse phenomenon|C1947910|[phpr]|["Pulse"-tx-33-"pulses"-verb-0]|TX|3935/6|
00000000|MMI|5.18|Pupil equal round and reacting to light|C1642390|[fndg]|["PERRL"-tx-33-"PERRL"-noun-0]|TX|3831/5|
00000000|MMI|5.18|Report (document)|C0684224|[inpr]|["Reports"-tx-25-"Reports"-noun-0]|TX|3247/7|
00000000|MMI|5.18|Reporting|C0700287|[hlca]|["reports"-tx-25-"Reports"-noun-0]|TX|3247/7|
00000000|MMI|5.18|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-11-"ALLERGY"-noun-0]|TX|1802/7|
00000000|MMI|5.18|SHE gene|C1822717|[gngm]|["SHE"-tx-57-"Shes"-noun-0]|TX|5388/4|
00000000|MMI|5.18|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|244/7|
00000000|MMI|5.18|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|244/7|
00000000|MMI|5.18|Stop (Instruction Imperative)|C1947925|[acty]|["Stop"-tx-8-"stop"-verb-0]|TX|1328/4|
00000000|MMI|5.18|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-15-"Symptoms"-noun-0]|TX|2496/8|
00000000|MMI|5.18|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-15-"Symptoms"-noun-0]|TX|2496/8|
00000000|MMI|5.18|TAC1 wt Allele|C1705924|[gngm]|["NKA"-tx-11-"NKA"-noun-0]|TX|1811/3|
00000000|MMI|5.18|Taken|C1883727|[cnce]|["Taken"-tx-19-"taken"-verb-0]|TX|2775/5|
00000000|MMI|5.18|Universal restriction modifier (core metadata concept)|C3539085|[idcn]|["All"-tx-26-"ALL"-noun-0]|TX|3490/3|
00000000|MMI|5.18|Usage|C0457083|[ftcn]|["uses"-tx-18-"uses"-verb-0]|TX|2729/4|
00000000|MMI|5.18|Use - dosing instruction imperative|C1947944|[inpr]|["Use"-tx-18-"uses"-verb-0]|TX|2729/4|
00000000|MMI|5.18|Warmer, device|C0184348|[medd]|["Warm"-tx-33-"warm"-adj-0]|TX|3948/4|
00000000|MMI|5.18|aVL - Lead site|C0449216|[spco]|["aVL"-tx-35-"AVL"-noun-0]|TX|4247/3|
00000000|MMI|5.18|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-8-"ATORVASTATIN"-noun-0]|TX|1160/12|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-14-"TREATMENTS/PROCEDURES"-noun-0]|TX|2142/21|
00000000|MMI|5.18|warming process|C0687712|[npop]|["warm"-tx-33-"warm"-adj-0]|TX|3948/4|
00000000|MMI|4.12|Does sit up|C0560837|[fndg]|["sit up"-tx-17-"sat up"-verb-0]|TX|2711/6|
00000000|MMI|4.12|research data|C0681873|[resa]|["study data"-tx-34-"STUDIES/DATA"-noun-0]|TX|4039/12|
00000000|MMI|3.88|Complication of procedure|C0742724|[fndg]|["Procedure complication"-tx-50-"procedural complications"-noun-1]|TX|5078/24|
00000000|MMI|3.82|Short|C1806781|[qnco]|["Shortest"-tx-11-"Shortness"-noun-0]|TX|1832/9|
00000000|MMI|3.82|Short Value|C2350002|[qnco]|["Short"-tx-11-"Shortness"-noun-0]|TX|1832/9|
00000000|MMI|3.78|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-12-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1853/9,1873/9|
00000000|MMI|3.78|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-12-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1853/9,1873/9|
00000000|MMI|3.75|Additional comments|C1830770|[fndg]|["Additional comments"-tx-59-"ADDITIONAL COMMENTS"-noun-0]|TX|5567/19|
00000000|MMI|3.75|Chest discomfort|C0235710|[sosy]|["CHEST DISCOMFORT"-tx-14-"chest discomfort"-noun-0]|TX|2405/16|
00000000|MMI|3.75|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-12-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1863/19|
00000000|MMI|3.74|Domestic activities|C0441660|[dora]|["house activity"-tx-8-"House ACTIVITY"-noun-0]|TX|1571/5,1601/8|
00000000|MMI|3.71|Nutrition management|C1258068|[hlca]|["Nutrition management"-tx-58-"nutrition management"-noun-0]|TX|5484/9,5509/10|
00000000|MMI|3.68|68|C0450387|[inpr]|["68"-tx-33-"68"-fraction-0]|TX|3782/2|
00000000|MMI|3.68|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-33-"ABD"-noun-0]|TX|3890/3|
00000000|MMI|3.68|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-33-"ABD"-noun-1]|TX|3890/3|
00000000|MMI|3.68|Act Relationship Subset - previous|C1552607|[tmco]|["previous"-tx-7-"Previous"-adj-0]|TX|828/8|
00000000|MMI|3.68|Anterior thoracic region|C1527391|[blor]|["Chest"-tx-33-"CHEST"-noun-0]|TX|3850/5|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|377/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|377/9|
00000000|MMI|3.68|Computed Tomography Study File|C3888140|[inpr]|["CT"-tx-34-"CT"-noun-0]|TX|4056/2|
00000000|MMI|3.68|Congestion|C0700148|[patf]|["Congestion"-tx-43-"congestion"-noun-0]|TX|4700/10|
00000000|MMI|3.68|Deterioration of status|C1279889|[fndg]|["Worse"-tx-17-"worse"-adj-0]|TX|2643/5|
00000000|MMI|3.68|Ground Glass Opacity|C3827002|[fndg]|["Ground Glass Opacity"-tx-34-"ground glass opacity"-noun-1]|TX|4115/20|
00000000|MMI|3.68|HEENT|C1512338|[blor]|["HEENT"-tx-33-"HEENT"-noun-0]|TX|3824/5|
00000000|MMI|3.68|Infusion pump Alert priority PH|C4049686|[fndg]|["PH"-tx-3-"PH"-noun-0]|TX|420/2|
00000000|MMI|3.68|K Prime|C1708601|[qnco]|["K'"-tx-1-"K"-noun-0]|TX|406/1|
00000000|MMI|3.68|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-8-"lt"-noun-0]|TX|1142/2|
00000000|MMI|3.68|Potassium Ion|C0597277|[elii,phsu]|["K+"-tx-1-"K"-noun-0]|TX|406/1|
00000000|MMI|3.68|Previous|C0205156|[tmco]|["Previous"-tx-7-"Previous"-adj-0]|TX|828/8|
00000000|MMI|3.68|Stat (do immediately)|C0205548|[tmco]|["Immediately"-tx-17-"immediately"-adv-0]|TX|2690/11|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-4-"STATUS"-noun-0]|TX|429/6|
00000000|MMI|3.68|Stenting|C2348535|[topp]|["Stenting"-tx-49-"stenting"-noun-0]|TX|5065/8|
00000000|MMI|3.68|Stepdaughter|C0337554|[famg]|["Stepdaughter"-tx-29-"stepdaughter"-noun-0]|TX|3673/12|
00000000|MMI|3.68|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-8-"lt"-noun-0]|TX|1142/2|
00000000|MMI|3.68|Tissue Congestion|C2826600|[fndg]|["CONGESTION"-tx-43-"congestion"-noun-0]|TX|4700/10|
00000000|MMI|3.68|Weekly|C0332174|[tmco]|["/week"-tx-11-"week"-noun-0]|TX|1795/4|
00000000|MMI|3.68|Worsening pattern|C0332271|[qlco]|["worse"-tx-17-"worse"-adj-0]|TX|2643/5|
00000000|MMI|3.68|ph+|C0450407|[fndg]|["ph+"-tx-3-"PH"-noun-0]|TX|420/2|
00000000|MMI|3.68|ph++|C0450408|[fndg]|["ph++"-tx-3-"PH"-noun-0]|TX|420/2|
00000000|MMI|3.68|ph+++|C0450409|[fndg]|["ph+++"-tx-3-"PH"-noun-0]|TX|420/2|
00000000|MMI|3.68|site-specific telomere resolvase activity|C1622890|[moft]|["ResT"-tx-15-"rest"-noun-0]|TX|2517/4|
00000000|MMI|3.68|week|C0439230|[tmco]|["WEEK"-tx-11-"week"-noun-0]|TX|1795/4|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|122/13|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-61-"ENTERED"-verb-0]|TX|5698/7|
00000000|MMI|3.63|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-15-"activity"-noun-0]|TX|2536/8|
00000000|MMI|3.63|31|C0450355|[inpr]|["31"-tx-37-"31"-fraction-0]|TX|4368/2|
00000000|MMI|3.63|Active|C0205177|[ftcn]|["Activity"-tx-15-"activity"-noun-0]|TX|2536/8|
00000000|MMI|3.63|Activities|C0441655|[acty]|["ACTIVITY"-tx-15-"activity"-noun-0]|TX|2536/8|
00000000|MMI|3.63|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-15-"activity"-noun-0]|TX|2536/8|
00000000|MMI|3.63|Actual Discomfort|C2364135|[sosy]|["Discomfort"-tx-14-"discomfort"-noun-0]|TX|2411/10|
00000000|MMI|3.63|Block Specimens|C1533157|[sbst]|["Blocks"-tx-14-"blocks"-noun-0]|TX|2488/6|
00000000|MMI|3.63|Block Unit of Distance|C3811660|[qnco]|["BLOCKS"-tx-14-"blocks"-noun-0]|TX|2488/6|
00000000|MMI|3.63|Blocking|C0332206|[ftcn]|["blocks"-tx-14-"blocks"-noun-0]|TX|2488/6|
00000000|MMI|3.63|Diarrhea Adverse Event|C1963091|[fndg]|["Diarrhea"-tx-21-"diarrhea"-noun-1]|TX|2922/8|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|447/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|447/11|
00000000|MMI|3.63|Dosage|C0178602|[qnco]|["DOSE"-tx-8-"dose"-noun-0]|TX|1438/4|
00000000|MMI|3.63|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-8-"dose"-noun-0]|TX|1438/4|
00000000|MMI|3.63|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-22-"ED"-noun-0]|TX|2935/2|
00000000|MMI|3.63|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-15-"activity"-noun-0]|TX|2536/8|
00000000|MMI|3.63|GEN1 gene|C2239486|[gngm]|["Gen"-tx-33-"GEN"-noun-0]|TX|3799/3|
00000000|MMI|3.63|HP gene|C1415692|[gngm]|["Bp"-tx-22-"BP"-noun-0]|TX|2946/2|
00000000|MMI|3.63|HP wt Allele|C1708288|[gngm]|["BP"-tx-22-"BP"-noun-0]|TX|2946/2|
00000000|MMI|3.63|Increased sweating|C0700590|[sosy]|["DIAPHORESIS"-tx-16-"diaphoresis"-noun-1]|TX|2571/11|
00000000|MMI|3.63|Insulin Drug Class|C3714501|[horm,phsu]|["INSULIN"-tx-8-"INSULIN"-noun-0]|TX|1460/7|
00000000|MMI|3.63|Insulin [EPC]|C1579433|[phsu]|["Insulin"-tx-8-"INSULIN"-noun-0]|TX|1460/7|
00000000|MMI|3.63|Malaise|C0231218|[sosy]|["DISCOMFORT"-tx-14-"discomfort"-noun-0]|TX|2411/10|
00000000|MMI|3.63|Obstruction|C0028778|[patf]|["blocks"-tx-14-"blocks"-noun-0]|TX|2488/6|
00000000|MMI|3.63|Operational Compliance|C3244300|[idcn]|["compliance"-tx-14-"compliance"-noun-0]|TX|2335/10|
00000000|MMI|3.63|Pairing Events Domain|C3541314|[inpr]|["PA"-tx-37-"PA"-noun-0]|TX|4365/2|
00000000|MMI|3.63|Percent Activity|C0439167|[qnco]|["% Activity"-tx-15-"activity"-noun-0]|TX|2536/8|
00000000|MMI|3.63|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-15-"activity"-noun-0]|TX|2536/8|
00000000|MMI|3.63|Recombinant Insulin|C1533581|[aapp,horm,phsu]|["INSULIN"-tx-8-"INSULIN"-noun-0]|TX|1460/7|
00000000|MMI|3.63|Unit dose|C0869039|[qnco]|["Dose"-tx-8-"dose"-noun-0]|TX|1438/4|
00000000|MMI|3.61|ASAH1 gene|C1412573|[gngm]|["AC"-tx-8-"AC"-noun-0]|TX|1499/2|
00000000|MMI|3.61|ASAH1 wt Allele|C3539770|[gngm]|["AC"-tx-8-"AC"-noun-0]|TX|1499/2|
00000000|MMI|3.61|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-12-"OPERATIONS"-noun-0]|TX|2040/10|
00000000|MMI|3.61|Glonoine, nitroglycerine, Homeopathic preparation|C0885378|[orch,phsu]|["nitroglycerine"-tx-8-"NITROGLYCERIN"-noun-0]|TX|1063/13|
00000000|MMI|3.61|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-12-"OPERATIONS"-noun-0]|TX|2040/10|
00000000|MMI|3.60|Pressure (finding)|C0460139|[fndg]|["pressures"-tx-37-"pressures"-noun-0]|TX|4339/9|
00000000|MMI|3.60|Discharge to home|C0184713|[topp]|["Discharge home"-tx-57-"discharged home"-noun-0]|TX|5393/10,5407/4|
00000000|MMI|3.60|Offspring|C0680063|[famg]|["Children"-tx-28-"children"-noun-0]|TX|3620/8|
00000000|MMI|3.60|Per Nanoliter|C3892223|[qnco]|["/nL"-tx-24-"nl"-noun-0]|TX|3243/2|
00000000|MMI|3.60|nanolitre|C0560008|[qnco]|["nL"-tx-24-"nl"-noun-0]|TX|3243/2|
00000000|MMI|3.59|Respiratory Domain|C2986904|[idcn]|["RE"-tx-58-"re"-noun-0]|TX|5498/2|
00000000|MMI|3.59|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-58-"re"-noun-0]|TX|5498/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.59|Atenolol 100 MG|C0983887|[clnd]|["Atenolol 100 MG"-tx-8-"ATENOLOL 100 MG"-noun-0]|TX|1540/15|
00000000|MMI|3.59|Divorced state|C0086170|[fndg]|["DIVORCED"-tx-27-"Divorced"-verb-0]|TX|3561/8|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-62-"END"-noun-0]|TX|5780/3|
00000000|MMI|3.59|Physical Exam Domain|C1744699|[inpr]|["Physical Exam"-tx-33-"PHYSICAL EXAM"-noun-0]|TX|3744/13|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-12-"Responsible"-adj-0]|TX|1884/11|
00000000|MMI|3.59|Source|C0449416|[fndg]|["Source"-tx-28-"source"-noun-0]|TX|3639/6|
00000000|MMI|3.59|Term Source|C1705919|[inpr]|["Source"-tx-28-"source"-noun-0]|TX|3639/6|
00000000|MMI|3.59|Euvolemia|C1845208|[fndg]|["Euvolemia"-tx-53-"euvolemic"-adj-0]|TX|5253/9|
00000000|MMI|3.58|Dyspnea on exertion|C0231807|[sosy]|["Exertional dyspnoea"-tx-14-"exertional dyspnea"-noun-0]|TX|2372/18|
00000000|MMI|3.57|Fill|C1708059|[acty]|["Fill"-tx-37-"filling"-noun-0]|TX|4331/7|
00000000|MMI|3.57|NADPH:sulfur oxidoreductase activity|C2700623|[moft]|["NSR"-tx-35-"NSR"-noun-0]|TX|4180/3|
00000000|MMI|3.57|Neutral Sidebent Rotated|C1704493|[patf]|["NSR"-tx-35-"NSR"-noun-0]|TX|4180/3|
00000000|MMI|3.57|Pillow|C0182291|[mnob]|["pillows"-tx-18-"pillows"-noun-0]|TX|2736/7|
00000000|MMI|3.56|Cardiology service|C3887620|[hcro]|["Cardiology"-tx-8-"Cardiology"-noun-0]|TX|1703/10|
00000000|MMI|3.56|Changed status|C0443172|[qnco]|["changes"-tx-35-"changes"-verb-0]|TX|4209/7|
00000000|MMI|3.56|Changing|C0392747|[ftcn]|["changes"-tx-35-"changes"-verb-0]|TX|4209/7|
00000000|MMI|3.56|Delta (difference)|C1705241|[qnco]|["Change"-tx-35-"changes"-verb-0]|TX|4209/7|
00000000|MMI|3.56|ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS|C3540048|[enzy,phsu]|["ENZYMES"-tx-44-"enzymes"-noun-0]|TX|4744/7|
00000000|MMI|3.56|Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|C3540772|[enzy,phsu]|["Enzymes"-tx-44-"enzymes"-noun-0]|TX|4744/7|
00000000|MMI|3.56|Enzymes for ALIMENTARY TRACT AND METABOLISM|C3542456|[enzy,phsu]|["Enzymes"-tx-44-"enzymes"-noun-0]|TX|4744/7|
00000000|MMI|3.56|Enzymes, antithrombotic|C3541394|[enzy,phsu]|["Enzymes"-tx-44-"enzymes"-noun-0]|TX|4744/7|
00000000|MMI|3.56|Enzymes, hematological|C3540017|[enzy,phsu]|["Enzymes"-tx-44-"enzymes"-noun-0]|TX|4744/7|
00000000|MMI|3.56|Enzymes, peripheral vasodilators|C3540790|[enzy,phsu]|["Enzymes"-tx-44-"enzymes"-noun-0]|TX|4744/7|
00000000|MMI|3.56|Minor (value)|C0205165|[qlco]|["Minor"-tx-35-"minor"-adj-0]|TX|4234/5|
00000000|MMI|3.56|Patient Class - Outpatient|C1549405|[clas]|["Outpatient"-tx-57-"outpatient"-noun-0]|TX|5455/10|
00000000|MMI|3.56|Referral category - Outpatient|C1548439|[idcn]|["Outpatient"-tx-57-"outpatient"-noun-0]|TX|5455/10|
00000000|MMI|3.56|contextual factors|C0542559|[ftcn]|["Setting"-tx-57-"setting"-noun-0]|TX|5466/7|
00000000|MMI|3.56|day|C0439228|[tmco]|["DAYS"-tx-20-"days"-noun-0]|TX|2847/4|
00000000|MMI|3.56|{Setting}|C1318139|[qnco]|["{Setting}"-tx-57-"setting"-noun-0]|TX|5466/7|
00000000|MMI|3.55|Switch Device Component|C1707719|[mnob]|["Switch"-tx-52-"switched"-verb-0]|TX|5164/8|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|348/4|
00000000|MMI|3.55|Present|C0150312|[qnco]|["Present"-tx-14-"presents"-verb-0]|TX|2346/8|
00000000|MMI|3.55|Presentation|C0449450|[idcn]|["Present"-tx-14-"presents"-verb-0]|TX|2346/8|
00000000|MMI|3.55|month|C0439231|[tmco]|["MONTHS"-tx-14-"months"-noun-0]|TX|2362/6|
00000000|MMI|3.54|Basal Diet|C2983588|[food]|["DIET"-tx-8-"DIET"-noun-0]|TX|1565/4|
00000000|MMI|3.54|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-8-"DIET"-noun-0]|TX|1565/4|
00000000|MMI|3.54|Entire mouth region|C1267547|[blor]|["Mouth, NOS"-tx-8-"mouth"-noun-0]|TX|1534/5|
00000000|MMI|3.54|Entire oral cavity|C1278910|[blor]|["Mouth"-tx-8-"mouth"-noun-0]|TX|1534/5|
00000000|MMI|3.54|Oral region|C0230028|[blor]|["Mouth"-tx-8-"mouth"-noun-0]|TX|1534/5|
00000000|MMI|3.54|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-8-"DIET"-noun-0]|TX|1565/4|
00000000|MMI|3.54|Pancreatitis Adverse Event|C1963198|[fndg]|["Pancreatitis"-tx-23-"PANCREATITIS"-noun-0]|TX|3129/12|
00000000|MMI|3.53|1-2|C3843716|[fndg]|["1-2"-tx-8-"1/2"-fraction-0]|TX|1434/3|
00000000|MMI|3.53|1/2|C0580272|[inpr]|["1/2"-tx-8-"1/2"-fraction-0]|TX|1434/3|
00000000|MMI|3.53|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|335/3|
00000000|MMI|3.53|Left side of heart|C0225809|[blor]|["left heart"-tx-38-"Left heart"-noun-0]|TX|4375/10|
00000000|MMI|3.53|Phase I/II Trial|C1519043|[resa]|["1-2"-tx-8-"1/2"-fraction-0]|TX|1434/3|
00000000|MMI|3.53|chest burning|C0740396|[sosy]|["burning chest"-tx-14-"burning chest"-noun-0]|TX|2396/7,2405/5|
00000000|MMI|3.50|100%|C3817553|[qnco]|["100%"-tx-8-"100"-integer-0]|TX|1146/3|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-12-"Causing"-adj-0]|TX|1912/7|
00000000|MMI|3.50|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|171/5|
00000000|MMI|3.50|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|171/5|
00000000|MMI|3.50|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|171/5|
00000000|MMI|3.50|Helpful|C3898897|[qlco]|["Helpful"-tx-29-"helpful"-adj-0]|TX|3665/7|
00000000|MMI|3.50|Infrequent|C0521114|[tmco]|["Rare"-tx-31-"Rare"-adj-0]|TX|3698/4|
00000000|MMI|3.50|M NOS ANTIBODY|C0369637|[aapp,imft]|["M NOS"-tx-3-"M"-noun-0]|TX|418/1|
00000000|MMI|3.50|M+ (tumor staging)|C0441923|[inpr]|["M+"-tx-3-"M"-noun-0]|TX|418/1|
00000000|MMI|3.50|MAS1L gene|C1422304|[gngm]|["MRG"-tx-33-"MRG"-noun-0]|TX|3886/3|
00000000|MMI|3.50|Per Liter|C3642217|[qnco]|["/L"-tx-34-"L"-noun-0]|TX|4138/1|
00000000|MMI|3.50|Pulmonary ventilator management|C1315068|[hlca]|["PULM"-tx-43-"pulm"-adj-0]|TX|4695/4|
00000000|MMI|3.50|Rare|C0522498|[qlco]|["Rare"-tx-31-"Rare"-adj-0]|TX|3698/4|
00000000|MMI|3.50|Retinoic Acid Response Element|C1514917|[gngm]|["RARE"-tx-31-"Rare"-adj-0]|TX|3698/4|
00000000|MMI|3.50|Saint Helena Islands|C0038108|[geoa]|["SH"-tx-26-"SH"-noun-0]|TX|3525/2|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|373/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|373/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-61-"dictated"-adj-0]|TX|5681/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-61-"dictated"-adj-0]|TX|5681/8|
00000000|MMI|3.50|liter/second|C0439394|[qnco]|["l's"-tx-34-"L"-noun-0]|TX|4138/1|
00000000|MMI|3.50|upper case letter ell|C1706495|[inpr]|["L-"-tx-34-"L"-noun-0]|TX|4138/1|
00000000|MMI|3.50|1 - 3|C3843504|[fndg]|["1 - 3"-tx-8-"1 3"-integer-0]|TX|1094/1,1111/1|
00000000|MMI|3.49|Lisinopril 30 MG|C0987220|[clnd]|["Lisinopril 30 MG"-tx-4-"LISINOPRIL 30 MG"-noun-0]|TX|545/16|
00000000|MMI|3.49|Right side of heart|C0225808|[blor]|["Right heart"-tx-37-"right-heart"-noun-0]|TX|4319/11|
00000000|MMI|3.48|Titrate|C1883350|[hlca]|["Titrate"-tx-52-"Titrated"-adj-0]|TX|5132/8|
00000000|MMI|3.48|Associated with|C0332281|[qlco]|["Associated"-tx-16-"associated"-adj-0]|TX|2553/10|
00000000|MMI|3.48|Character String Data Type|C3272372|[inpr]|["ST"-tx-35-"ST"-adj-0]|TX|4204/2|
00000000|MMI|3.48|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-8-"FOLLOW UP"-adj-0]|TX|1635/9|
00000000|MMI|3.48|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-8-"FOLLOW UP"-adj-0]|TX|1635/9|
00000000|MMI|3.48|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-8-"FOLLOW UP"-adj-0]|TX|1635/9|
00000000|MMI|3.48|Four|C0205450|[qnco]|["Four"-tx-14-"four"-word_numeral-0]|TX|2483/4|
00000000|MMI|3.48|Good|C0205170|[qlco]|["Well"-tx-33-"well"-adv-0]|TX|3957/4|
00000000|MMI|3.48|HPS4 gene|C1423767|[gngm]|["LE"-tx-20-"LE"-noun-0]|TX|2867/2|
00000000|MMI|3.48|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-20-"LE"-noun-0]|TX|2867/2|
00000000|MMI|3.48|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-20-"LE"-noun-0]|TX|2867/2|
00000000|MMI|3.48|N not otherwise specified Antibody|C0369718|[aapp,imft]|["N NOS"-tx-21-"N"-noun-0]|TX|2918/1|
00000000|MMI|3.48|N+ (tumor staging)|C0441922|[inpr]|["N+"-tx-21-"N"-noun-0]|TX|2918/1|
00000000|MMI|3.48|NPO - Nothing by mouth|C0419179|[topp]|["NPO"-tx-8-"npo"-noun-0]|TX|1448/3|
00000000|MMI|3.48|Nausea Adverse Event|C1963179|[patf]|["Nausea"-tx-16-"nausea"-noun-1]|TX|2564/6|
00000000|MMI|3.48|Notolabrus celidotus|C3542930|[fish]|["spotty"-tx-14-"spotty"-adj-0]|TX|2324/6|
00000000|MMI|3.48|Patchy distribution|C0205413|[qlco]|["Spotty"-tx-14-"spotty"-adj-0]|TX|2324/6|
00000000|MMI|3.48|Primary|C0205225|[qlco]|["Principal"-tx-12-"PRINCIPAL"-adj-0]|TX|1853/9|
00000000|MMI|3.48|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-8-"regular exercise"-noun-0]|TX|1618/16|
00000000|MMI|3.48|S1|C3715215|[fndg]|["S1"-tx-33-"S1"-noun-0]|TX|3873/2|
00000000|MMI|3.48|Spots on skin|C0848332|[sosy]|["Spotty"-tx-14-"spotty"-adj-0]|TX|2324/6|
00000000|MMI|3.48|Teaching principal|C0401925|[prog]|["Principal"-tx-12-"PRINCIPAL"-adj-0]|TX|1853/9|
00000000|MMI|3.48|Testicular Cancer Serum Markers Test Result S1|C3814877|[lbtr]|["S1"-tx-33-"S1"-noun-0]|TX|3873/2|
00000000|MMI|3.48|Well|C3146287|[mnob]|["Well"-tx-33-"well"-adv-0]|TX|3957/4|
00000000|MMI|3.48|acute|C0205178|[tmco]|["ACUTE"-tx-35-"acute"-adj-0]|TX|4198/5|
00000000|MMI|3.48|follow-up|C1522577|[hlca]|["Follow Up"-tx-8-"FOLLOW UP"-adj-0]|TX|1635/9|
00000000|MMI|3.47|Administration procedure|C1533734|[topp]|["Treatment"-tx-12-"Treatment"-noun-0]|TX|2021/9|
00000000|MMI|3.47|Base|C0178499|[chvf]|["Base"-tx-33-"base"-noun-0]|TX|3864/4|
00000000|MMI|3.47|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-12-"Treatment"-noun-0]|TX|2021/9|
00000000|MMI|3.47|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-33-"BS"-noun-0]|TX|3906/2|
00000000|MMI|3.47|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-33-"BS"-noun-0]|TX|3906/2|
00000000|MMI|3.47|Boolean|C1552663|[inpr]|["BL"-tx-33-"BL"-noun-0]|TX|3861/2|
00000000|MMI|3.47|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-33-"BS"-noun-0]|TX|3906/2|
00000000|MMI|3.47|Dental Base|C1880279|[bodm]|["Base"-tx-33-"base"-noun-0]|TX|3864/4|
00000000|MMI|3.47|Low Mitosis-Karyorrhexis Index|C3890211|[qnco]|["Low"-tx-34-"low"-adj-0]|TX|4073/3|
00000000|MMI|3.47|NT5E wt Allele|C3889152|[gngm]|["NT"-tx-33-"NT"-noun-0]|TX|3899/2|
00000000|MMI|3.47|No treatment required for|C0332126|[qlco]|["NT"-tx-33-"NT"-noun-0]|TX|3899/2|
00000000|MMI|3.47|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-59-"Stable"-adj-0]|TX|5609/6|
00000000|MMI|3.47|Saint Barthelemy|C2827109|[geoa]|["BL"-tx-33-"BL"-noun-0]|TX|3861/2|
00000000|MMI|3.47|Stable status|C0205360|[qlco]|["STABLE"-tx-59-"Stable"-adj-0]|TX|5609/6|
00000000|MMI|3.47|Structure of base of heart|C0225810|[blor]|["Base"-tx-33-"base"-noun-0]|TX|3864/4|
00000000|MMI|3.47|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-12-"Treatment"-noun-0]|TX|2021/9|E02
00000000|MMI|3.47|Treating|C1522326|[ftcn]|["Treatment"-tx-12-"Treatment"-noun-0]|TX|2021/9|
00000000|MMI|3.47|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-12-"Treatment"-noun-0]|TX|2021/9|
00000000|MMI|3.47|Tyrosine Nitration|C4050156|[moft]|["NT"-tx-33-"NT"-noun-0]|TX|3899/2|
00000000|MMI|3.47|low|C0205251|[qlco]|["Low"-tx-34-"low"-adj-0]|TX|4073/3|
00000000|MMI|3.47|low confidentiality|C1550472|[inpr]|["low"-tx-34-"low"-adj-0]|TX|4073/3|
00000000|MMI|3.47|low exposure|C4048187|[qlco]|["low"-tx-34-"low"-adj-0]|TX|4073/3|
00000000|MMI|3.47|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-12-"Treatment"-noun-0]|TX|2021/9|
00000000|MMI|3.46|CNDP2 gene|C1539110|[gngm]|["CN2"-tx-33-"CNII"-noun-0]|TX|3978/4|
00000000|MMI|3.46|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-9-"Call"-noun-0]|TX|1740/4|
00000000|MMI|3.46|Decision|C0679006|[menp]|["Call"-tx-9-"Call"-noun-0]|TX|1740/4|
00000000|MMI|3.46|Dependent - ability|C0851827|[qlco]|["Dependent"-tx-34-"dependent"-adj-0]|TX|4150/9|
00000000|MMI|3.46|Gender Status - Intact|C1554187|[fndg]|["Intact"-tx-33-"intact"-adj-1]|TX|3987/6|
00000000|MMI|3.46|Intact|C0205266|[qlco]|["Intact"-tx-33-"intact"-adj-0]|TX|3987/6|
00000000|MMI|3.46|NT5C2 gene|C1417862|[gngm]|["cN-II"-tx-33-"CNII"-noun-0]|TX|3978/4|
00000000|MMI|3.46|NT5C2 wt Allele|C3540519|[gngm]|["cN-II"-tx-33-"CNII"-noun-0]|TX|3978/4|
00000000|MMI|3.46|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-9-"Call"-noun-0]|TX|1740/4|
00000000|MMI|3.46|dependent|C3244310|[ftcn]|["dependent"-tx-34-"dependent"-adj-0]|TX|4150/9|
00000000|MMI|3.46|Asymmetry|C0332514|[spco]|["Asymmetric"-tx-34-"asymmetric"-adj-0]|TX|4100/10|
00000000|MMI|3.46|Concentric|C0439744|[spco]|["Concentric"-tx-24-"concentric"-adj-0]|TX|3224/10|
00000000|MMI|3.46|Difficult (qualifier value)|C0332218|[qlco]|["Difficult"-tx-28-"difficult"-adj-0]|TX|3587/9|
00000000|MMI|3.46|Has difficulty doing (qualifier value)|C1299586|[fndg]|["Difficult"-tx-28-"difficult"-adj-0]|TX|3587/9|
00000000|MMI|3.46|Lisinopril 20 MG|C0987219|[clnd]|["Lisinopril 20 MG"-tx-26-"Lisinopril 20 MG"-noun-0]|TX|3396/16|
00000000|MMI|3.46|Past|C1444637|[tmco]|["Past"-tx-28-"past"-adj-0]|TX|3582/4|
00000000|MMI|3.45|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-8-"chol"-noun-0]|TX|1583/4|
00000000|MMI|3.45|Perfuse|C1549542|[ftcn]|["Perfuse"-tx-33-"perfused"-adj-0]|TX|3962/8|
00000000|MMI|3.45|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-8-"TAB"-noun-0]|TX|1096/3|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-12-"Study"-noun-0]|TX|1902/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-12-"Study"-noun-0]|TX|1902/5|
00000000|MMI|3.45|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-26-"QHS"-noun-0]|TX|3373/3|
00000000|MMI|3.44|Past Week|C2987125|[tmco]|["Past Week"-tx-19-"past week"-noun-0]|TX|2806/9|
00000000|MMI|3.44|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-14-"h/o"-noun-0]|TX|2288/3|
00000000|MMI|3.44|20%|C3842589|[fndg]|["20%"-tx-52-"20"-integer-0]|TX|5217/2|
00000000|MMI|3.44|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|96/14|
00000000|MMI|3.44|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|96/14|
00000000|MMI|3.44|Increase|C0442805|[ftcn]|["Increased"-tx-52-"increased"-adj-0]|TX|5191/9|
00000000|MMI|3.44|Increased|C0205217|[qnco]|["Increased"-tx-52-"increased"-adj-0]|TX|5191/9|
00000000|MMI|3.44|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-1-"PM"-adj-0]|TX|296/2|
00000000|MMI|3.44|Problem|C0033213|[fndg]|["Problem"-tx-42-"PROBLEM"-noun-0]|TX|4635/7|
00000000|MMI|3.44|Problem:Find:Pt:^Patient:Nom|C3854081|[clna]|["Problem"-tx-42-"PROBLEM"-noun-0]|TX|4635/7|
00000000|MMI|3.43|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-45-"cardiac"-adj-0]|TX|4814/7|
00000000|MMI|3.43|Cough Adverse Event|C1961131|[fndg]|["Cough"-tx-20-"cough"-noun-0]|TX|2855/5|
00000000|MMI|3.43|Device Motor|C1705994|[mnob]|["Motor"-tx-26-"motor"-noun-0]|TX|3541/5|
00000000|MMI|3.43|Two|C0205448|[qnco]|["Two"-tx-20-"two"-noun-0]|TX|2843/3|
00000000|MMI|3.43|motor movement|C1513492|[ftcn]|["Motor"-tx-26-"motor"-noun-0]|TX|3541/5|
00000000|MMI|3.43|Basilar Rales|C0240859|[fndg]|["Rales"-tx-22-"rales"-noun-0]|TX|2985/5|
00000000|MMI|3.43|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-14-"BRIEF"-adj-0]|TX|2185/5|
00000000|MMI|3.43|Brief|C1879313|[tmco]|["Brief"-tx-14-"BRIEF"-adj-0]|TX|2185/5|
00000000|MMI|